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Fluorescence resonance energy transfer (FRET)-based biosensors have been 
designed to fluorometrically detect everything from proteolytic activity to receptor-ligand 
interactions and structural changes in proteins. While a wide variety of fluorophores have 
demonstrated effectiveness in FRET probes, several potential sensor components are 
particularly notable. Semiconductor quantum dots (QDs) are attractive FRET donors 
because they are rather bright, exhibit high quantum yields, and their nanoparticulate 
structure enables the attachment of multiple acceptor molecules. Fluorescent proteins 
(FPs) are also of particular interest for fluorescent biosensors because design elements 
necessary for signal transduction, probe assembly, and device delivery and localization 
for intracellular applications can all be genetically incorporated into the FP polypeptide. 
The studies described in this thesis elucidate the important parameters for 
concerted QD-FP FRET probe design. Experimental results clarify issues of FRET pair 
selection, probe assembly, and donor-acceptor distance for the multivalent systems. 
Various analysis approaches are compared and guidelines asserted based on the results. 
To demonstrate the effectiveness of the QD-FP FRET probe platform, a ratiometric pH 
sensor is presented. The sensor, which uses the intrinsic pH-sensitivity of the FP 
mOrange to modulate the FP/QD emission ratio, exhibits a 20-fold change in its 
ratiometric measurement over a physiologically interesting pH range, making it a prime 
candidate for intracellular imaging applications. 
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CHAPTER 1  
INTRODUCTION 
The development of fluorescent biosensors has provided a wealth of information 
to the biomedical community through their application in a wide range of modalities, 
including solution studies, flow cytometery and microfluidic devices, and fluorescence 
microscopy. Fluorescent indicators are typically more sensitive than their colorimetric 
counterparts and can be used in tandem for multiplexed analysis. The diversity of 
fluorochromes spans the visible wavelengths into the near-infrared, ranges in molecular 
weight from small molecule organic dyes to massive phycoerythrins and nanocrystals, 
and can be synthesized through organic chemistry, biochemical methodologies, or 
inorganic nanoparticle synthesis. Recent developments in nanobiotechnology have 
further enhanced the range of possibilities for fluorescent indicators, offering increased 
potential for multiplexing, sensitivity, and resistance to photobleaching. 
The objective of this thesis research was to develop a novel quantum dot-
fluorescent protein (QD-FP) probe platform that could be used to generate highly 
sensitive and specific fluorescent sensors. Integrating the customization of fluorescent 
proteins through genetic engineering with the unique optical properties of semiconductor 
QDs creates a unique inorganic-biomolecule hybrid that could be adapted to a number of 
sensing applications. It was hypothesized that, due to the exceptional brightness and 
photostability of quantum dots in comparison to organic dyes, the development of a 
switchable QD probe would produce indicators with heightened sensitivity and resistance 
to photobleaching. The rationale for this work was that the development of more sensitive 
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indicators would provide unique and important tools for both cellular biology studies and 
biomedical research. Such indicators could be adapted to monitor any number of 
environmental cues as well as small analyte concentration, enzyme activity, and ligand 
binding and could be applied in a range of sensing modalities. In particular, live-cell 
imaging studies could benefit from the development of fluorescence resonance energy 
transfer (FRET)-based ratiometric biosensors that resist photobleaching. The project 
entails developing FRET probes consisting of QD donors and fluorescent protein (FP) 
acceptors, investigating the properties of both the QD and FP that affect probe assembly 
and functionality, and producing a functional biosensor based on this probe platform, 
specifically a pH sensor. 
 
To address the hypothesis, three specific aims were pursued. 
 
SPECIFIC AIM 1: Investigate the self-assembly of QDs and His-tagged FPs using QDs 
with similar spectral properties and a variety of coating chemistries. 
We hypothesized that histidines incorporated in a polypeptide tail chelate zinc 
ions in the ZnS capping layer of CdSe/ZnS quantum dots with sufficient affinities to 
produce stable, self-assembled probes when the polypeptide is able to access the ZnS 
surface. By using fluorescent proteins containing a His-tag as a FRET acceptor, the 
proximity-dependent change in the fluorescent spectra was used to assess the 
polyhistidine-QD interaction for eight different QD coating varieties. The distance 
between the donor and acceptor was estimated and correlated with measurements of 
various QD characteristics in order to compile information about the likely mechanisms 
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of the interactions between each of the QDs and the protein. In cases where defects in the 
organic coating appear to have left the ZnS shell accessible, direct binding of the His-tag 
to the nanocrystal surface resulted in self-assembly with reduced donor-acceptor 
distances and increased FRET efficiencies. In other cases, the organic coating effectively 
shielded the QD from direct binding of the polypeptide, but electrostatic interactions or 
the coordination of supplemented Ni2+ ions still facilitated associations between the QD 
and the protein, albeit with greater donor-acceptor distances. Finally, the presence of 
PEG chains on the surface of other QD varieties effectively blocked the self-assembly of 
proteins via steric hinderance. The results of this study give indications as to which QD 
varieties make the most successful FRET donors and what conjugation strategies may be 
most appropriate for each QD coating type. 
 
SPECIFIC AIM 2: Examine the FRET efficiency of various QD-FP FRET pairs. 
We hypothesized that a variety of QD and FP pairings could be used effectively if 
the spectral properties of the donor and acceptor were well matched. We analyzed a 
number of pairings, looking at the effect of the spectral overlap on the FRET efficiency 
as well as the influence of various properties of the fluorescent protein, such as the length 
of the polyhistidine tail, the molar extinction coefficient, quantum yield, and molecular 
weight. We observed that the optical properties of the protein, particularly its quantum 
yield, could dictate the most appropriate analysis techniques for a given FRET pair. 
Specifically, proteins with poor quantum yields, such as mCherry, can operate as 
effective protein quenchers, but are not desirable for ratiometric measurements because 
of their low sensitized emission. In contrast, FP acceptors with high quantum yields like 
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tdTomato show significant increases in their acceptor emission to donor emission ratios 
as the number of acceptor molecules per QD increases, making them good candidates for 
ratiometric FRET probe designs. These findings elucidate important parameters to 
consider when choosing the most appropriate FP for a given biosensor application. 
 
SPECIFIC AIM 3: Design and evaluate a functional QD-FP FRET probe, specifically a 
ratiometric pH sensor. 
We hypothesized that a ratiometric FRET-based biosensor could be designed 
using a fluorescent protein that showed the appropriate pH-sensitivity. The pH-specific 
spectral properties of two variants of the fluorescent protein mOrange were elucidated, 
while QDs and bioconjugation strategies were assessed for their stability over a range of 
pHs. The fluorescence spectra and FRET efficiency of two QD-mOrange hybrid probes 
were evaluated for their pH sensitivity. Each of these probes demonstrated a dramatic 
difference in the ratio of the acceptor emission to donor emission over a relatively short 
pH range. The probes’ high signal-to-noise ratio and large, pH-dependent change in the 
FRET efficiency indicates that this probe has significant potential for intracellular 
imaging applications. 
 
Collectively, these studies contribute to a better understanding of how to apply 
nanobiotechnology to biosensor design. The results herein shed light on how nanoparticle 
properties affect the formation of inorganic-biomolecule hybrid devices, reveal the utility 
of QDs and FPs as efficient FRET donor-acceptor pairs, and demonstrate the 
effectiveness of the QD-FP pairs as a biosensor, specifically as a ratiometric pH monitor. 
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As probe development continues, this and other QD-based FRET biosensors will enable 




CHAPTER 2  
RESEARCH SIGNIFICANCE 
The use of fluorescent biosensors has expanded precipitously in recent decades 
because of their high sensitivity, diversity, and simplicity (1). Probes that have been 
developed for a vast array of analytes, enzymes, and environmental cues can be utilized 
in conjunction with a variety of instruments, such as fluorescence microscopes, flow 
cytometers, fluorimeters, or multiplate readers. This versatility guarantees that optical 
sensing will continue to be a powerful tool in biomedical research. Driving the increased 
application of fluorescence-based biosensing has been the continued development of 
several relatively new and dynamic fluorophores. While traditional small molecule 
organic dyes continue to play a very important role in many sensing applications, the 
introduction of green fluorescent protein (GFP) and its analogues as genetically 
encodable fluorophores as well as optically active nanomaterials like semiconductor 
quantum dots (QDs) has transformed biosensor design (2, 3). 
Many fluorescent biosensors utilize fluorescence (or Förster) resonance energy 
transfer (FRET) for signal transduction. FRET is the distance-dependent, non-radiative 
transfer of energy from one fluorophore (the donor) to an acceptor: either another 
fluorophore or a non-fluorescent quencher (4). FRET signals can be reversibly or 
irreversibly modulated in response to a biological stimulus or environmental cue. Both 
QDs and GFP-like fluorescent proteins (FPs) have been used as donors and acceptors in 
FRET-based biosensors. QDs have become a favorite FRET donor because their high 
quantum yield and the multivalancy of the nanoparticle platform increase FRET 
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efficiencies even as the high molar extinction coefficient of the QD results in bright 
signals that are ideal for fluorescence microscopy (5). Fluorescent proteins, in contrast, 
are heavily utilized in biosensor designs because they, by nature as biomolecules, interact 
with the biological environment in ways that make them innate biosensors. Cleavable 
polypeptides can be incorporated into their structure to create enzyme activity assays, 
protein transduction domains can be incorporated into the protein for localization to 
specific subcellular compartments, and molecular biology techniques can be used to coax 
cells into expressing the biosensors themselves, simplifying production and delivery of 
the fluorophores to an on-location event (6, 7). 
While both of these fluorescent indicators have been garnering attention, and even 
a Nobel prize (8, 9), independently, no biosensors in the literature combine the unique 
optical properties of the QD with the inherent sensing versatility of fluorescent proteins. 
The work described in this thesis does exactly that.  
First, the polyhistidine-mediated self-assembly of biomolecules to semiconductor 
QDs was examined and evaluated for a number of QD coating types. Although this form 
of protein-QD self-assembly had been described for dihydrolipoic acid (DHLA) coated 
QDs (10, 11), it was unclear whether this bioconjugation modality would be successful 
with other varieties of QDs. The demonstration of successful binding to QDs coated with 
several different approaches, including commercially available varieties, expanded the 
range of known options available for QD-biomolecule hybrids assembled via 
polyhisitinde-mediated self-assembly. Furthermore, the examination of what QD 
parameters determined whether or not self-assembly would be successful enables the 
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prediction of what other coating types are most likely to behave similarly. The straight-
forward FRET assay that is described can be used to verify such predictions. 
QDs have been described as FRET donors paired with organic fluorophores, 
organic quenchers, and gold nanoparticles as the acceptor (12-14). Although dye-labeled 
proteins have been used as FRET acceptors as well (11), the added complication of 
chemically labeling the protein with a fluorophore can be eliminated by adapting 
fluorescent proteins as FRET acceptors. In the first published study documenting the 
effectiveness of fluorescent protein acceptors (15), we demonstrate several successful 
FRET pairs. Analytical approaches focusing only on the donor emission and FRET 
efficiency are compared to ratiometric methods. 
Finally, we demonstrate the effective utility of a QD-FP hybrid probe in the form 
of a FRET-based, ratiometric pH sensor. A very few reports of QD-based pH sensors 
have emerged in the literature (16-18), but none have exhibited a sufficient sensitivity 
that would make them promising candidates for intracellular imaging. Two different 
monomeric fluorescent proteins were evaluated for their pH-dependent optical properties 
and their effectiveness as FRET acceptors to a QD donor. With a 20-fold change in the 
acceptor emission to donor emission ratio over a pH range that is physiologically 
interesting, these probes hold promise as intracellular imaging agents. Potential 
applications include endosomal tracking or the elucidation of delivery pathways used by 
various cell-penetrating peptides with model nanoparticle-protein drug delivery devices. 
 
By outlining and exploring a number of design parameters specific to the QD and 
the FP as well as detailing the interaction between the two, these studies provide a guide 
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for QD-FP hybrid biosensor design as well as demonstrating an example of a successful 




CHAPTER 3  
LITERATURE REVIEW 
FLUORESCENCE RESONANCE ENERGY TRANSFER 
Fluorescence (or Förster) Resonance Energy Transfer (FRET) is the non-radiative 
transmission of energy from an excited donor molecule to an acceptor molecule in close 
proximity; the acceptor can subsequently radiatively emit this energy in the form of a 
lower-energy photon than was used to excite the donor (4). The energy transmission 
depends on several factors, most notably the spectral overlap between the donor emission 
and the acceptor absorbance and the proximity of the two molecules (4). FRET is 
inversely proportional to the distance between the donor and acceptor to the sixth power, 
making it highly sensitive to small changes in the distance between the donor and 
acceptor (4). This property has made FRET a valuable tool in a number of biophysical 
and biochemical studies, such as investigations into receptor-ligand interactions (19), 
protein phosphorylation (20), proteolysis (21), and nucleic acid hybridization (22). The 
fluorescence emission of the donor moiety can be modulated by either another 
fluorophore or a non-fluorescent quencher. The first results in sensitized emission of the 
acceptor fluorophore, while the second quenches the donor without emitting any photons 
(Figure 3.1). Typical FRET studies utilize either organic fluorophores or fluorescent 
proteins as the donor and one of these or an organic quencher as the acceptor, but the use 
of these molecules is accompanied by some inherent limitations, including susceptibility 
to chemical or photodegradation, photobleaching, and broad excitation and emission 
spectra, which can result in crosstalk between the two fluorophores during detection (6). 
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Fluorescent proteins have been used to develop an entire class of genetically-
encoded FRET biosensors. Separately, fluorescent nanoparticles of semiconductor metals 
have been tested as both FRET donors and, more rarely, acceptors. Details of these types 
of FRET probes and specific examples of their application are included below. 
 
Figure 3.1: FRET modulation of the emission of a fluorescent donor. 
In the presence of a quencher, the emission of the FRET donor fluorophore is decreased. 
In close proximity to a fluorescent acceptor, the emission from the FRET donor is 




Quantum Dot Crystal Properties 
Semiconductor quantum dots (QDs) are crystalline nanoparticles often composed 
of group II-VI or III-V elements from the periodic table with diameters smaller than their 
exciton Bohr radius (24), typically just a few nanometers in diameter. Spherical CdTe 
QDs emitting visible wavelengths, for example, range in diameter from 1.5 to 4.2 nm 
(Figure 3.2) (23). Quantum confinement effects present at this size range give rise to 
distinctive optical and electronic properties that are not present in the bulk materials. QDs 
most commonly used in the visible wavelength range are CdSe/ZnS core-shell 
nanoparticles; the CdSe core confers the particle its unique optical properties, while the 
ZnS shell serves as a passivation layer, protecting the core from oxidation and enhancing 
the quantum yield (25, 26). 
High quality inorganic core/shell QDs are typically synthesized in a step-wise 
reaction using organometallic precursors (e.g., trioctylphosphine selenium (TOP:Se), 
 
Figure 3.2: Series of CdTe QDs with fluorescence emissions from 515 to 655 nm. 
The QD color is tuned by modulating the size of the nanocrystal with larger particles 
exhibiting more red-shifted emission. Reproduced with permission from Kairdolf, Smith 
et al. 2008 (23). 
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cadmium acetylacetonate, diethylzinc and hexamethyldisilathiane) at high temperatures 
(25-28). Since these nanoparticles are grown and coated with a mixture of 
trioctylphosphine, trioctylphosphine oxide, and hexadecylamine, they are water insoluble 
and must be coated with an organic layer to be used in biological applications (see 
below). 
The broad excitation range of QDs paired with narrow, symmetrical emissions 
make QDs an interesting option for fluorescence sensing applications. Excitation of QDs 
is possible with photons of higher energy than the semiconductor bandgap. Because a 
large number of energy states exist within the QD, a broad range of excitation 
wavelengths is possible, from the first exciton, or quantum-confinement, peak to shorter 
wavelengths with increasing molar extinction coefficients through the UV (Figure 3.3, 
top). QDs are optimally excited in the UV, but two-photon excitation can also be used to 
induce QD emission (29), a technique that reduces background autofluorescence and cell 
damage from UV irradiation in live-cell imaging (30, 31). Although the excitation 
wavelength range for QDs is broad, QD emission peaks are narrow and symmetrical 
(Figure 3.3, bottom). QDs have uniquely tunable emissions moderated by adjusting the 
diameter of the CdSe core (32). Next generation QDs made with other semiconductor 
configurations allow for continuous tuning of the QD emission without changing the 
particle size. Examples include CdSeTe alloys that are tuned by varying the alloy 
concentration (33) and CdTe cores paired with various compressive shell materials that 
affect QD properties through lattice strain (34).  
The combination of the broad excitation peak and narrow emission peak make 
QDs well suited to multiplexing applications because several QDs can be excited 
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simultaneously and their emission peaks can be easily distinguished (24, 35-37). This is 
in contrast to organic fluorophores and fluorescent proteins, whose broad, asymmetrical 
emission peaks often overlap, reducing the number of discrete colors that can be 
discerned. 
In addition to their unique spectral signatures, QDs have gained attention for 
fluorescence detection because they exhibit brightnesses up to 1,000-fold higher than 
most organic fluorophores. This arises from a combination of molar extinction 
coefficients 10-100 times higher than those measured for organic fluorophores (38, 39) 




Figure 3.3: Characteristic QD absorption and emission spectra. 
Absorption (top) and emission (bottom) spectra of water-soluble CdSe/ZnS core-shell 
QDs (from left to right) with peak emissions at 490, 520, 540, 560, and 585 nm. The 
absorbance spectra are normalized to the first exciton peak. 
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Quantum Dot Coatings 
Because the inorganic synthesis of the core-shell QDs results in a water-insoluble 
colloid, a number of coating strategies have been devised to transfer the particles into 
aqueous solutions, a necessary step for biological applications (40). While all of the 
coatings result in a hydrophilic outer layer to interface with aqueous solutions, two basic 
approaches are most commonly used. In the first, amphiphilic materials are used such 
that their hydrophobic portions associate with the hydrophobic surfactants left on the 
crystalline surface following the inorganic synthesis and a hydrophilic region exposed to 
the surrounding media. In the second approach, the hydrophobic surfactant is removed 
and replaced with molecules that bind directly to the nanocrystal through ligand 
exchange. The colloids that result from these coating procedures are stabilized 
electrostatically, with steric hinderance, or both. 
The first ligand exchange coatings utilized small molecules containing thiol 
groups that bind directly to the ZnS capping layer of the particle and contained a carboxyl 
group that is deprotonated at physiological pHs, stabilizing the colloid with electrostatic 
repulsion (41). While this approach results in small, uniform QDs that are water soluble, 
the thiol-QD bond is known to dissociate causing precipitation of the particles over time 
(42, 43). This coating strategy has been improved by using molecules containing 
bidentate thiols such as dihydrolipoic acid (DHLA), which dissociate from the particle at 
a slower rate, improving the long-term stability of the coating (44-46). These coatings are 
very thin, resulting in quantum dots with hydrodynamic diameters around 10 nm, but 
they are prone to complications from the environment such as aggregation in acidic 
media (45). Ligand exchange coating of CdS nanocrystals that are capped with just a thin 
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shell of ZnS also seems to result in QDs with low quantum yields relative to the starting 
material with typical research articles citing QYs on the order of 10-30% QY (45).  
More recently, PEGylated ligands have been used in ligand exchange protocols. 
These colloids are stabilized via steric hinderance, making them less susceptible to their 
environment and reducing non-specific interactions when used in applications such as 
intracellular imaging (45, 47-49). There are also a few recent reports of QD coating 
protocols that use ligand exchange with small molecules, but under gentle conditions that 
maintain better QYs (50, 51), and multidentate ligands that form thin but robust coatings 
(52). Small, bright QDs such as these hold great potential for both labeling and sensing 
applications. A number of amphiphilic moieties have been used to coat QDs without 
removing the hydrophobic surfactant layer, most notably alkylated polycarboxylates (53, 
54), amphiphilic block copolymers (37, 55), and lipid-poly(ethylene glycol) (lipid-PEGs) 
that form a micelle-like layer around the QD (56). These coatings have the advantage of 
maintaining high QD QYs, but at the expense of an increased hydrodynamic diameter 
(55). While the amphiphilic polymer-coated QDs can be primarily stabilized 
electrostatically by using a polymer that contains a high density of carboxyl groups at the 
media interface, the inclusion of PEG chains at the surface reduces non-specific 
interactions with the environment (57). A schematic diagram of several QD coating 
approaches is included in Figure 3.4 and a comparison of various QD coatings is included 






Figure 3.4: Schematic of some QD coating approaches. 
Ligand exchange coatings like dihydrolipoic acid (DHLA), mercaptoacetic acid (MAA), 
and PEGylated DHLA derivatives (DHLA-PEG750-OH shown here) remove the nonpolar 
surfactant residue remaining on the QD surface following inorganic synthesis (trioctyl 
phosphine (TOP) shown here). Other approaches include using lipid-PEG (such as 
DSPE-mPEG2000) or amphiphilic polymers to interface with the hydrophobic surfactant 
rather than removing it. 
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Bioconjugation to QDs 
The conjugation of biomolecules to QDs has been used to functionalize the 
nanoparticles for any number of applications, such as immunohistochemistry using QD-
labeled antibodies (54), nucleic acid hybridization requiring DNA-tagged QDs (58, 59), 
and proteolytic activity using QDs bound to dye-labeled peptides (14, 60). While there 
are enough possible bioconjugation strategies to fill a book (61), a few approaches that 
have become standards in the field are discussed here. 
The assembly of biomolecules and QDs can be achieved with covalent chemistry, 
most frequently using a carbodiimide linker, as well as streptavidin-biotin binding or 
affinity based coordination based on either electrostatic interactions or metal 
coordination. Each of these approaches has advantages and limitations that need to be 
considered when designing a hybrid device. 
Covalent coupling. Covalent coupling provides the most durable attachment of a 
protein to a QD. Many of the QD organic coatings used to water-solubolize QDs result in 
carboxyl groups exposed at the surface, so heterobifunctional cross-linkers that facilitate 
couplings between carboxyl groups and other functional groups, such as amines or thiols, 
are particularly useful for covalently attaching biomolecules to the QD surface. Cross-
linking reagents, such as 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC), used 
alone or in conjunction with N-hydroxysuccinimide (NHS) or its more water-soluble 
analogue sulfo-NHS (S-NHS), are readily commercially available and have been used 
extensively in the literature (62-64). EDC activates the carboxylic acid, priming it for 
reaction with a primary amine to form a stable amide bond (65). Both the EDC and the 
activated carboxyl group are highly water-labile, but the lifetime of the activated 
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carboxylic acid can be extended with the addition of NHS or S-NHS, which form a more 
stable intermediate (61). With or without NHS, reaction conditions must be tweaked to 
promote conjugation while minimizing aggregation. One-step reactions involve 
incubating the carboxylated nanoparticle with a large excess of a biomolecule, e.g. a 40-
fold molar excess of protein, and a huge excess of EDC (up to a 1500-fold molar excess). 
In this protocol, the EDC is able to activate the carboxylates on the nanoparticle for 
reaction with the N-terminal amine as well as any lysines present in the protein. The EDC 
also, however, activates the carboxylic acids of the aspartic acid and glutamic acid 
residues in the protein. When protein amines react with activated carboxyl groups on 
other proteins, undesirable protein polymerization can result (61). These protein polymers 
may be bound to the nanoparticle surface, increasing its size and potentially negatively 
affecting other colloidal properties, or may be independent of the QD, but complicate 
purification of the conjugate. The size of the polymerized polymer may preclude them 
from being eliminated with oft-used centrifugal filtration devices. 
In contrast, supplementation with NHS or S-NHS allows for use of a two-step 
reaction because of the increased stability the active intermediate. In the two step 
reaction, the nanoparticle is incubated with EDC and an NHS derivative to form activated 
carboxylic acids. The excess EDC is either removed with a centrifugal filtration device or 
quenched with the addition of β-mercaptoethanol prior to the addition of the biomolecule. 
The two-step process eliminates the possibility of protein polymerization, but aggregation 
of the particles is now a potential hazard as the extended lifetime of the activated 
carboxylate increases the chances that a protein will encounter two QDs and bind them 
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both. Careful testing of reaction conditions, particularly the concentration of the 
reactants, is important to minimize this undesirable aggregation. 
Carbodiimide chemistry is particularly useful for the bioconjugation of proteins to 
QDs both because the QDs and biomolecules frequently exhibit the necessary carboxylic 
acids and primary amines, respectively, and because the zero-length crosslinking agents 
like EDC bind the two moieties directly to one another without the addition of any 
superfluous atoms (61). In instances where the addition of a short linker is acceptable, 
homo- and heterobifunctional cross-linkers expand the repertoire of applicable functional 
groups. Amine-functionalized QDs, for example, have been conjugated to protein amines 
and thiols using the homobifunctional cross-linker bis(sulfosuccinimidyl) suberate (BS3) 
and the heterobifunctional succinimidyl 4-[N-maleimidomethyl] cyclohexane-1-
carboxylate (SMCC), respectively (66, 67). 
While it is not in the scope of this thesis to provide a comprehensive examination 
of all of the possible means of covalent coupling that are applicable to QD 
bioconjugations, the discussion of the EDC coupling is intended to convey the 
accessibility of such bioconjugation methods, but also the potential for unintended 
products. The over-arching benefit of using convalent conjugation for QD-biomolecule 
probe assemblies is the stability of the final product. This is highly desirable in 
applications where further modification and down-stream processing of the probe is 
necessary, when probes are prepared in bulk for use at a later date, or if potential 
dissociation of some of the biomolecules could significantly and detrimentally impact 
assay results. Unfortunately, the covalent bioconjugations may cause nanoparticle 
aggregation, may result in a relatively low number of proteins per nanoparticle compared 
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to the reaction ratios, and often require purification steps that are also a source of loss, 
depressing the overall yield of the functional construct (61). In addition, the convalent 
reactions result in a lack control of component stochiometries and biomolecule 
orientation; heterogeneous conjugation, for example, may cause proteins to attach in an 
unproductive manner or to lose activity. 
Streptavidin-biotin affinity. Streptavidin-biotin binding is another common and 
useful coupling mechanism that utilizes exceptionally simple protocols, provided the 
constituent components are already functionalized with the required streptavidin and 
biotin moieties. With femptomolar binding affinities, the streptavidin-biotin interaction is 
often considered to be effectively as stable as a covalent bond (68, 69). QDs have been 
derivatized with both streptavidin and biotin for labeling and imaging applications (13, 
49, 62, 70-72). 
With a molecular weight of ca. 53 kD, the addition of multiple streptavidin 
molecules to a single QD adds considerably to the overall size of the nanoparticle 
construct. This extra protein bulk could be detrimental in applications where the increase 
in size may impair function. FRET-based biosensors, for example, require short distances 
between their fluorescent donors and acceptors. As the efficiency of energy transfer is 
inversely related to the donor-acceptor distance to the sixth power (4), the additional 
separation by a few nanometers due to the size of streptavidin can dramatically reduce 
FRET efficiency.  
Probe assemblies based on streptavidin-biotin binding are likely to remain popular 
for many applications because of the shear ease of their implementation, particularly as 
both streptavidin-labeled QDs and kits designed to biotinylate biomolecules are 
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commercially available. In some applications, however, the advantages of the 
streptavidin-biotin interaction may be overshadowed by the tetrameric nature of 
streptavidin, which can result in undesired multiple binding events and induce 
aggregation (73). The development of monovalent streptavidin QD conjugates that 
contain only one biotin binding site per QD have the potential to mitigate this concern 
(74). 
Affinity-driven self-assembly. An alternative bioconjugation approach is derived 
from the affinities between biomolecular components and various substrates. These range 
in strength and specificity from electrostatic interactions to metal chelation to interactions 
culled from phage display (44, 46, 75-78). Although the binding affinities of these 
reactions cannot rival that of avidin-biotin, advantages arise because the minimal affinity 
tag can be genetically engineered into a protein of interest and bind to the QD without 
necessitating additional functionalization of the nanoparticle. Self-assembly based 
coupling requires only small tags, is facile, is typically not intrusive on the other 
components of the nanoparticle system, is orthogonal to most biological structures and 
activity, provides reasonable control over the relative component stoichiometries, and 
utilizes well-established protocols. 
A specific example of one such small affinity tag is the polyhistidine sequence 
(His-tag), which has an affinity for divalent cations. It was discovered that His-tag 
chelation of metal ions, such as Ni2+, Zn2+, or Cu2+, could be used to purify recombinant 
proteins using immobilized metal affinity chromatography (IMAC) (79). More recently, 
His-tags have been used to bind biomolecules, including proteins, peptides, and even His-
modified DNA, to QDs displaying zinc ions on their surface in the form of the ZnS 
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capping layer of the CdSe/ZnS core-shell nanoparticles (10, 15, 78, 80-82). Although this 
coupling technique has been used with success in several QD-based sensing applications, 
the characteristics of the QD-polyhisitidine interaction appear to vary depending on the 
particular organic coating used to confer water solubility of the QDs (83). Chapter 5 of 
this thesis addresses this interaction, and its coating dependence at length. 
Other small molecule polypeptides that have been used to bind directly to the QD 
surface typically have a high cysteine content for dative binding (51, 70), but electrostatic 
interactions have also been used to associate positively charged regions of a biomolecule 
with negatively charged QD coatings (44, 46). While this interaction would be transient 
and sensitive to environmental factors, such as high salt or low pH, there may be 
instances when this bioconjugation strategy is sufficient, or even preferred. 
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Quantum Dots and FRET 
Quantum dots have been used in a variety of resonance energy transfer 
applications as FRET donors and, occasionally, as acceptors. Reports of QD FRET 
systems describe QD as donors paired with organic fluorophores, organic quenchers, or 
gold nanoparticles as the acceptor (12-14). The many advantages of QDs as a FRET 
donor include their high quantum yield, which improves FRET efficiency, and the 
particulate nature of the QDs, which enables the binding of multiple acceptor molecules 
per QD. As can be seen in Figure 3.5, the use of multiple acceptor molecules per donor 
 
Figure 3.5: Distance dependance of FRET efficiency for multivalent systems. 




shifts the distance versus FRET efficiency trace, increasing the FRET efficiency at a 
given distance with each additional acceptor. Likewise, having an average of less than 
one acceptor per donor molecule, say in the case of an incomplete conjugation that leaves 
some QDs unlabeled, greatly reduces the FRET efficiency at a given distance. It should 
also be noted that the multiple acceptor effect is non-linear such that the more acceptors 
present per donor, the less the impact of adding one more. That is to say that a more 
significant impact on the FRET efficiency is seen when the number of acceptors is 
increased from one to two than with an increase the number of acceptors per donor from 
eight to nine.  
The broad excitation range of the QDs combined with a Stokes shift much larger 
than that seen for organic fluorophores or fluorescent proteins allows for excitation of 
QDs far from the excitation ranges of other fluorophores, reducing crosstalk when used in 
tandem with conventional dyes. This improves the signal-to-noise of QD-based FRET 
devices as more of the emission observed from the acceptor molecules is sensitized 
emission rather than a result of direct excitation. 
The variety of FRET-based QD probes for protease activity demonstrate the 
versatility of QDs for FRET biosensing. In this sensor type, cleavable peptides are used 
to link the QD to another fluorophore or quencher. Gold nanoparticles (12), organic dyes 
(14, 60), organic quencher molecules (14), and recently a fluorescent protein (84) have all 
been used as acceptor molecules in this scheme with varying levels of success. The QD-
gold nanoparticle device suffered from unacceptably slow cleavage, presumably due to 
the difficulty the enzyme may have had in accessing a cleavage site between the two 
nanoparticles, highlighting a concern that arises when the size of the nanoparticles or 
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overall construct used grow ungainly (12), but reasonable results were seen with both the 
dye-labeled peptide and fluorescent protein biosensor designs (14, 84). In a different 
approach, luciferase molecules containing a protease cleavage site were bound to QD to 




Figure 3.6: Schematics of QD biosensors for protease cleavage. 
Top: A peptide containing an enzymatic cleavage site and an organic fluorophore or 
quencher is bound to a QD. The donor QD is quenched by FRET to the dye/quencher 
until protease cleavage releases the acceptor and QD photoluminescence is restored. 
Reprinted with permission (14). 
Bottom: The bioluminescent protein luciferase acts as a BRET donor to a QD acceptor as 
long as the cleavable tether that links the two is intact. After protease cleavage, the 




GFP-LIKE FLUORESCENT PROTEINS 
Source, History, and Development of GFP-like Fluorescent Proteins 
Green fluorescent protein (GFP) is a naturally occurring fluorophore isolated from 
Aequorea jellyfish. While observations of the fluorescent properties protein isolations 
from the organism had been described in the literature as early as the 1960s (87), the 
existence of the genetically encodable fluorophore did not capture the imagination of the 
bioscience community until the gene was cloned (88) and it was shown that protein 
expression of GFP in other organisms induced fluorescence in 1994 (7). That the gene 
alone contains all of the information necessary for chromophore development—that no 
jellyfish-specific enzymes are necessary—was dramatically significant. 
Since this groundbreaking discovery, which was later rewarded with the Nobel 
Prize in chemistry (8), the application of GFP and GFP-like fluorescent proteins to 
intracellular imaging and sensing applications has revolutionized cell biology. Proteins 
can be monitored in live cells with fluorescence microscopy by creating fusions with 
GFP, promoting the visualization of protein transport and localization. Cell processes can 
be observed using fluorescent protein-based biosensors, elucidating signaling pathways 
and protease activity (87). 
Since the discovery of the utility of GFP for cell biology studies, a number of 
other structural homologues to GFP have been discovered either through their isolation 
from natural sources, such as the cloning of DsRed from Discosoma coral (89, 90), or by 
mutagenesis of other fluorescent proteins to modify protein characteristics (91, 92). 
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Protein and Chromophore Structure 
Wild-type GFP consists of a single polypeptide chain 238 amino acids long and 
has a molecular weight around 27 kDa. Crystal structure analysis has revealed that the 
peptide chain folds into a compact cylinder composed of a rolled eleven-sheet β-barrel 
capped with short α-helices and loops. An α-helix containing the three amino acids that 
comprise the chromophore thread through the center of the so-called β-barrel (93). The 
posttranslational cyclization of the amino acids Ser65-Tyr66-Gly67 to form an imidazolone 
ring following protein folding is necessary for maturation of the chromophore, which has 
excitation peaks at 395 and 470 nm and emits at 504 nm (94). Proper folding and 
configuration of the residues adjacent to the chromophore is essential for fluorescence; 
the isolated chromophore is not fluorescent in aqueous solution (95). 
Although the red fluorescent protein isolated from coral Discosoma sp. and 
commercialized by Clontech as DsRed has only ~22% sequence homology to GFP, it 
maintains the same β-barrel structure and similar chromophore structure, albeit with a 
substitution of a glutamine for the GFP serine (96). The maturation of the DsRed 
chromophore involves the same cyclization as GFP, but is followed by oxidation of the 
Gln66 peptide bond . Native DsRed is an obligate tetramer, making it less than ideal for 
use as a fusion protein (90, 97), but mutations to the wild type DsRed have produced 
subsequent generations of proteins with improved properties for cell biology studies (91, 
92). 
The studies in this thesis utilize derivatives of DsRed belonging to the so-called 
“Fruit Basket” family of proteins. The three proteins of interest here evolved as follows. 
Tetrameric DsRed was mutated to form a stable dimer, from which a further point 
30 
 
mutation created the dimer dTomato. The plasmid for dTomato was cloned so to contain 
two Tomato genes in succession, linked end-to-end, creating the so-called tandem dimer, 
tdTomato (91). By creating this protein that is twice as large as the individual barrel 
structures that typically make up the GFP-like proteins, the designers were able to 
circumvent issues of protein aggregation that arise when using proteins that are obligate 
oligomers, simultaneously producing a protein that is twice as bright as the lone Tomato 
subunit. An alternative evolution focused on the amino acids at the interfaces of the 
subunits of the tetrameric DsRed. The resulting mRFP1 is stably monomeric; subsequent 
mutations have produced a series of GFP-like proteins with a variety of spectral 
properties. mOrange and mCherry were a result of those modifications. While mOrange 
and mCherry have similar molar extinction coefficients (about half that of tdTomato, as 
they also have half the chromophore), mCherry exhibits a significantly lower quantum 
yield than either mOrange or tdTomato. On the other hand, mOrange photobleaches 
much more rapidly than the other two proteins and is pH sensitive as well (91). While 
these are just a few of the rainbow of fluorescent proteins available, mCherry, mOrange, 
and tdTomato provide sufficient variety for the studies described in this thesis. In 
addition to their differences in size, brightness, photosensitivity, and pH sensitivity, they 
also represent a range of excitation and emission wavelengths. 
FRET Sensing with GFP-like Fluorescent Proteins 
FP-based FRET biosensors have been developed using several common 
methodologies that have been summarized as focusing on intermolecular interactions, 
intramolecular interactions, or proteolytic cleavage (3). To study binding interactions 
between proteins, for example, donor and acceptor fluorescent proteins are separately 
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fused to the proteins of interest. When the two FPs are brought into close proximity by 
the interaction of their fusion partners, a FRET signal will be observed, giving spatial and 
temporal information about their interaction. A similar mechanism was used to design a 
FP-FRET-based biosensor for cAMP: YFP was fused to protein kinase A and CFP to its 
cAMD-dependent binding substrate. With this indicator, a FRET signal is only produced 
when the presence of cAMP induces the binding of the two fusion partners (98, 99). 
In contrast to the binding-induced FRET seen with the intermolecular sensors, 
protease cleavage is detected when two FPs that are tethered to one another by a 
cleavable linker are separated by an enzymatic event. In this case either the loss of the 
FRET signal or the recovery of the donor signal can be monitored. The use of FRET 
sensors for caspase cleavage, for example, enabled the monitoring of caspase-8 activation 
during apoptosis, clarifying that caspase-8 is activated prior to caspase-3 (100).  
FP-FRET biosensors reliant on intramolecular sensory events are depicted in (a) – 
(c) of Figure 3.7. In all three instances, the donor and acceptor FPs are both fused to the 
sensory domain in one contiguous polypeptide, but the events to which the sensor reacts 
can vary (3, 101). The changes in FRET signal in response to intramolecular biosensing 
are a product in changes in the donor-acceptor distance rather than in absolute association 
or dissociation of the donor and acceptor FPs as with the intermolecular or protease 
sensors. 
FP FRET has revolutionized fluorescence sensing because the biosensors are 
genetically encodable: natural sensor domains are easily integrated into the design and 
biosensor-containing plasmids are readily introduced into most cell lines, making the 
sensors broadly applicable. Issues arise with interpreting FP-FRET data, however (102). 
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A major hurdle with FRET results is cross-talk, i.e. bleed-through, between two 
fluorophore colors. Cross-talk can occur when the acceptor is unintentionally excited 
with the excitation light intended for the donor, leading to acceptor emission due to direct 
excitation in addition to, and indistinguishable from, its sensitized emission. 
Alternatively, cross-talk occurs when the emission light form the donor bleeds through to 
the acceptor channel. Both of these instances are of particular concern with FP-FRET 





Figure 3.7: Schematic of various FP-based FRET biosensors. 
Representative FRET-based biosensors for small molecule detection and enzyme activity 
assays. FRET signal is moderated in response to (a) analyte-induced peptide association, 
(b) post-translational modification, (c) binding-induced conformational changes, and (d) 




It is clear that both QDs and GFP-like FPs have many characteristics that have 
facilitated their successful application in biosensing. The unique optical properties of 
QDs facilitate highly sensitive detection of multiple analytes through multiplexing. The 
broadening range of available FPs is expanding the possibilities for efficient FRET and 
multiplexing potential even as the variety of the genetically encoded biosensors expands. 
There were, however, no examples in the literature of these two fluorescent indicators 
being used in conjunction for FRET-based biosensing. The studies performed in the 
pursuit of this thesis aim to demonstrate the potential of using these two components in 
tandem. QD-FP hybrid devices exploit the advantages of each fluorophore by utilizing 
the QD brightness to enhance sensitivity and FRET efficiency and by genetically 
engineering sensor-specific regions directly into the FP. Important issues include, but are 
not limited to, the synthesis of such hybrid probes, i.e. QD-protein conjugation, and 




CHAPTER 4  
MATERIALS AND METHODS 
MATERIALS 
Quantum Dots 
Quantum dots (QDs) were acquired from several sources for the studies included 
in this thesis. Several varieties of EviTags produced by Evident Technologies (Troy, NY) 
were used in the completion of Aims 1 and 2 (Chapter 5 and Chapter 6). T2-MP EviTags 
are Evident Technologies’ CdSe/ZnS core-shell quantum dots, called EviDots, coated 
with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[polyethylene glycol-2000] 
(ammonium salt), i.e. DSPE-PEG2000, from Avanti Polar Lipids (Alabaster, Alabama). In 
Chapter 5, three different varieties of the EviTags emitting at 540 nm were tested, each 
with a slightly different lipid-PEG coating. Although all three varieties were made water 
soluble using DSPE-PEG2000, the functional group on the PEG terminus is varied, making 
three distinct quantum dots. Specifically, the lipid-PEG was terminated with either a 
carboxyl group, an amine, or a methoxyl group, forming the so-called carboxyl-
functionalized, amine-functionalized, and non-functionalized EviTags, respectively. In 
Chapter 6, all of the EviTags employed were carboxyl-functionalized, but three different 
wavelength emitters were utilized, specifically QDs emitting at 520 nm, 540 nm, and 560 
nm. (Note: EviTags are now sold as eFluor Nanocrystals by eBioscience in San Diego, 
CA). 
Qdot ITK quantum dots from Invitrogen’s Molecular Probes division (Eugene, 
OR) were included in the studies presented in Chapter 5 and Chapter 7. Qdot ITK 
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carboxyl quantum dots are CdSe/ZnS nanocrystals water-solubolized with a polymer that 
contains a high density of carboxyl groups at the particle surface. 545 nm Qdot ITK 
carboxyl quantum dots were employed in Chapter 5 while 525 nm Qdot ITK carboxyl 
quantum dots were used for the work presented in Chapter 7. The Qdot ITK carboxyl 
quantum dots are derivatized with the addition of amine-terminated PEG2000 molecules 
to create Qdot ITK amino-PEG quantum dots. Data using the 545 nm Qdot ITK amino-
PEG quantum dots are presented in Chapter 5. 
Quantum dots coated using ligand exchange were kindly provided by 
collaboration partners at the Naval Research Laboratories (NRL) in Bethesda, Maryland. 
These QDs are again CdSe/ZnS nanocrystals. In this case, however, the 
trioctylphosphine/trioctylphosphine oxide (TOP/TOPO) surfactant that is present on the 
surface of the nanoparticles following their synthesis in organic solvents was physically 
removed and replaced with a thiol-containing molecule, specifically dihydrolipoic acid 
(DHLA) or one of its derivatives. Three variants of DHLA-coated QDs were used in the 
study presented in Chapter 5. All three originated from the same batch of 550 nm 
emitting QDs and were coated with DHLA or DHLA derivatized with hydroxyl- or 
methoxy-PEG, i.e. DHLA-PEG600-OH and DHLA-PEG750-OCH3, respectively, also 
called DHLA-PEG and DHLA-mPEG. 
PCR Primers  
The dioxyribonucleic acid (DNA) primers used for modifications to plasmids in 
polymerase chain reaction (PCR) protocols were special ordered from Integrated DNA 





Luria Bertani (LB) agar, LB broth, ampicillin (Amp), chloramphenicol (Cam), 
lysozyme: chicken RZ3 (muramidase), isopropyl-β-D-thiogalactoside (IPTG), and 
imidazole were purchased from US Biological (Swampscott, MA). Phosphate buffered 
saline (PBS) envelopes, bovine serum albumin (BSA), sodium choloride, sodium 
phosphate, imidazole, Tris-EDTA (TE) buffer (50x solution), borax, and nickel (II) 
chloride were procured from Sigma Aldrich (St. Louis, MO). A HHHHHHHHHH 
peptide (His10) was custom synthesized by AnaSpec (San Jose, CA). 
Purified His-tagged maltose binding protein (His5-MBP) was provided by our 
collaborators at NRL. 
Table 4.1: List of PCR primers. 
Primer Primer Sequence Purificationa 
50 5’-/5Phos/CAT CAC CAT CAC CAT CAC GGA GGT GGA GTG AGC AAG GGC GAG GAG-3’ HPLC 
51 5’-/5Phos/CAT CAC CAT CAC CAT CAC CAT CAC CAT CAC GGA GGT GGA GTG AGC AAG GGC GAG GAG-3’ PAGE 
63 5’-/5Phos/GTG AGC AAG GGC GAG GAG-3’ S.D. 
91 5’-TAA TAC GAC TCA CTA TAG GG-3’ S.D. 
98 5’-ACC CCG CAT ATG TAT ATC TCC TTC TTA AAG-3’ S.D. 
114 5’-/5Phos/GAG GCC TGC TCC GAG CG-3’ S.D. 
116 5’-/5Phos/CCA GCC CAT GGT CTT CTT CTG-3’ S.D. 
118 5’-/5Phos/CTT CAG GGC GCC GTC CTC-3’ S.D. 
122 5’-/5Phos/GGC GAG AAC AAG CAG AGG CTG-3’ S.D. 
127 5’-TAG TTA TTG CTC AGC GGT GG-3’ S.D. 
132 5’-/5Phos/GGC GAG AAC AAG ATG AGG CTG AAG-3’ S.D. 
133 5’-/5Phos/CTT CAG GGC GCC GTC CTC-3’ S.D. 
134 5’-/5Phos/CGA GAT CAA GAA AAG GCT GAA GCT G-3’ S.D. 
135 5’-/5Phos/CCC TTC AGG GCG CCG TC-3’ S.D. 
145 5’-/5Phos/GAA TTC GAA GCT TGA TCC GGC TG-3’ S.D 
146 5’-/5Phos/TTA ACG ACG ACG ACG ACG ACG ACG ACG ACG CTT GTA CAG CTC GTC CAT GCC-3’ S.D. 






pRSET-b plasmids containing inserts for the fluorescent proteins (FP) mOrange, 
tdTomato, and mCherry were kindly provided by Roger Tsien’s laboratory at the 
University of California, San Diego. These plasmids were modified using a PCR 
insertion/deletion protocol to produce the control FPs, which lack a terminal polyhistidine 
sequence, and His6- and His10-FPs, which contain a polyhisitidine sequence linked to the 
fluorescent protein with three glycines. The forward primer #63 was used to produce the 
non-His-tagged control proteins (see Table 4.1), while the forward primers #50 and #51 
were used to create the His6- and His10-tagged proteins, respectively. In all three cases, 
the reverse primer #98 was used, which binds to the template plasmid in a position so as 
to remove an unnecessary multiple cloning site, a His6-tag that was present in the 
original plasmid, an Xpress Epitope, and an enterokinase cleavage site from the N-
terminus region of the original plasmid. In order to maintain a reasonable melting 
temperature for the PCR reaction, however, it was necessary to retain two non-critical 
amino acids at the N-terminus, specifically an arginine and a glycine.  
Phusion High-Fidelity Master Mix (New England Biolabs (NEB), Ipswich, MA) 
was used for all PCR reactions with 10 pg template DNA and 25 pmol of each primer per 
50 µl reaction. Thermocycler conditions were chosen as directed in the Phusion manual 
with an annealing temperature of 69.6˚C being used for each of the reactions described 
above. 
Following the PCR insertion or mutagenesis, which involved amplifying the 
entire plasmid in vitro and resulted in a linear plasmid, the plasmid was recircularized by 
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ligating its blunt ends using the NEB Quick Ligation Kit. After ligation, the plasmid 
DNA was transformed into a 50 µl aliquot of Subcloning Efficiency™ DH5α™ 
Competent Cells (Invitrogen) following the manufacturer’s protocol. In the final step of 
the transformation, cells were plated on LB agar plates containing Amp to select for 
plasmid incorporation and were grown overnight at 37˚C. Tubes containing 5 ml of LB 
Amp were inoculated with single colonies from the plates and grown overnight to 
produce cultures from which to isolate the plasmid. The Promega Wizard® Plus 
Miniprep Kit was then used as directed to purify the plasmid DNA. The plasmids were 
analyzed for concentration and purity using UV-Vis absorbance measurements at 230, 
260, and 280 nm with either an Ultrospec 2100 pro UV/Visible Spectrophotometer (GE 
Healthcare Life Sciences, Pittsburgh, PA) or a NanoDrop ND-1000 Spectrophotometer 
(Thermo Fisher Scientific, Inc., Wilmington, DE) before being sent to the Nevada 
Genomics Center (Reno, NV) for sequencing using primers #91 and #127 (Table 4.1). 
The non-fluorescent, non-chromogenic GFP-like protein His6-mCherry-NF was 
produced by making three single point mutations to the His6-mCherry plasmid produced 
as described above. The S144C, I161N, and Q163M mutations were introduced 
sequentially using PCR mutagenesis protocols. The pHis6-mCherry plasmid was first 
amplified using primers #114 and #116 (Table 4.1) to produce pHis6-mCherry-S144C. 
The resulting plasmid was ligated, transformed, amplified, purified, and sequenced as 
described above. The mutation process was repeated utilizing primers #118 and #122 to 
produce pHis6-mCherry-S144C-I161N and again with primers #132 and #133 to create 
pHis6-mCherry-S144C-I161N-Q163M. The mOrange M163K point mutation was 
introduced using primers #134 and #135. 
40 
 
FPs that contained a polyhistidine tag at the N-terminus and a polyarginine tail at 
the C-terminus were produced by modifying the pHis6-FP plasmids with the same PCR 
insertion protocol described above using primers #145 and #146 (Table 4.1). 
Protein Production and Purification 
Plasmids coding for the FPs were transformed into the Rosetta 2(DE3) strain of 
E.coli (Novagen, Madison, WI) per the manufacturer’s protocol and plated on 
LB/Amp/Cam agar plates for selection. Single colonies were plucked from the plates for 
overnight cultures in 10 mL LB/Amp/Cam broth grown at 30˚C and 200 rpm. The 
overnight cultures were used to inoculate 500 mL cultures, which were incubated at 37˚C 
and 200 rpm. After 3-4 hours, the cultures were induced with 0.5 mL of 1 M IPTG. After 
culturing another 5-6 hours at 37˚C or overnight at 30˚C, the E.coli were pelleted at 5,000 
rpm in 500 mL jars in a Beckman J2-21 centrifuge. The cell pellets were frozen at -20˚C 
until they were needed. 
The cell pellets containing expressed fluorescent protein were thawed and 
resuspended in 25 mL TE buffer. To digest the cells, the suspension was incubated with 
25 mg of lysozyme for one hour on ice. While on ice, the cells were further disrupted 
with five cycles of sonication (ten seconds on, ten seconds off) with the Branson Sonifier 
150 sonicator probe at level four. The cell slurry was centrifuged for fifteen minutes at 
15,000 rpm in 50 mL tubes in the Beckman JA-21 centrifuge to produce a cleared cell 
lysate. Ammonium sulfate precipitation was used to isolate the protein from the rest of 
the cell lysate. 
Chromatographic methods were used to extract each protein of interest from the 
protein mixture using an ÄKTAprime plus system (GE Healthcare, Piscataway, NJ). His-
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tagged protein precipitates were resuspended in HisTrap Binding Buffer (20 mM sodium 
phosphate, 0.5 M NaCl, 30 mM imidazole, pH 7.4) and centrifuged to remove any 
insoluble fractions. The His-tag facilitated binding of the protein to a 1 or 5 mL HisTrap 
HF column and the low concentration of imidazole in the binding buffer minimized non-
specific binding of non-His-tagged proteins. After washing with the binding buffer, the 
protein was eluted using a linear gradient that gradually increased the imidazole 
concentration up to 500 mM. The elution fractions containing the fluorescent protein 
were concentrated and buffer-exchanged into PBS using centrifugal filtration devices 
(Centricon Plus-20; Millipore, Bedford, MA). 
Purification of the untagged proteins required two discrete chromatographic 
methods used in sequence: proteins were separated first using a hydrophobic column 
(HiPrep 16/10 Butyl FF) followed by size-exclusion chromatography (HiPrep 16/60 
Sephacryl S-300 HR). The protein precipitate was solubolized in TE buffer containing 
30% ammonium sulfate and centrifuged to remove any insoluble proteins. Using this 
concentration of ammonium sulfate, the FPs were soluble in solution, but precipitated on 
the hydrophobic column. Following ample washing with that same buffer, a linear 
gradient that gradually eliminated the ammonium sulfate in the buffer was used to elute 
the protein. The elution fractions containing the fluorescent proteins were concentrated 
and buffer-exchanged into PBS using centrifugal filtration devices prior to size-exclusion 
chromatography (SEC). Following SEC the protein-containing fractions were again 
concentrated using the centrifugal filtration devices. 
The proteins were aliquoted into PCR tubes and snap frozen in liquid nitrogen as 
previously described (103). The protein purity was checked with SDS-PAGE, and the 
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protein concentrations were determined using a BCA Assay (Pierce, Rockford, IL) or by 
measuring the absorbance spectra of the protein solution and applying the molar 
extinction coefficients published in the literature (91) to calculate the concentration of 
functioning fluorophores. 
Circular Dichroism  
Circular dichroism was used to confirm the presence of the characteristic β-barrel 
structure of the GFP-like fluorescent proteins. This was used to verify that point 
mutations incorporated to produce the non-fluorescent GFP-like protein mCherry-NF did 
not inhibit the formation of the chromophore by dramatically altering the protein 
structure and tested whether structural changes in response to pH could explain the pH-
sensitivity of mOrange and mOrange M163K. Protein solutions at a concentration of 
either 20 or 30 µM were measured on a Jasco J-815 CD Spectrometer (Jasco, Inc., 
Easton, MD) with a 1 nm stepsize. The measurements of mOrange and mOrange M163K 
started in 20 mM phosphate buffered saline, pH 10.0, and were titrated with 1 N HCl. 
The recorded spectra in millidegrees of ellipticity (θ) were converted to mean 










θ , (1) 
where c is the concentration of the protein in mg/ml, l is the pathlength in cm, M is the 
protein molecular weight, and nr is the number of amino acid residues. All presented 
spectra are the average of three accumulations. 
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Quantum Dot and Fluorescent Protein Spectral Measurements 
The QD absorbance spectra of the stock solutions were taken using a NanoDrop 
ND-1000 with a stepsize of 3 nm. The QD emission spectra as well as the excitation and 
emission scans of the fluorescent proteins were all measured on a Tecan Safire multiplate 
reader (Durham, NC) using 1 nm stepsizes, excitation bandwidths of 12 nm, and emission 
bandwidths of 5 nm. Non-binding black flat-bottomed 384-well plates from Corning were 
used for all fluorescence measurements on the Tecan Safire. A 100 nM solution of the 
EviTags were used to take emission spectra with an excitation at 400 nm. The fluorescent 
proteins were diluted to 5 µM for the spectral measurements. The excitation spectrum of 
mOrange was taken from 450 – 590 nm with a fixed emission wavelength of 605 nm. 
The same protein was excited at 500 nm for the measurement of its emission. tdTomato 
was excited at 510 nm for the emission measurement, and the emission was fixed at 620 
nm while the excitation spectrum was taken. The excitation spectrum of mCherry was 
taken with a fixed emission wavelength of 650 nm, while the excitation wavelength was 
static at 550 nm during the emission scan. Spectra were graphed in Igor (v5.05A, 
Wavemetrics Inc., Lake Oswego, OR). 
Dynamic Light Scattering Measurements 
In order to make a proper comparison of the eight different quantum dots studied 
in Aim 1, the hydrodynamic diameter and zeta potential of each variety were measured. 
Dynamic light scattering (DLS) was used to measure the hydrodynamic diameter and zeta 
potential using the Nicomp 280 from Particle Sizing Systems (PSS; Goleta, CA). Each 
QD stock solution was diluted with distilled water and filtered through a 0.2 µm syringe 
filter before the hydrodynamic diameter was measured. The same sample was then 
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further diluted with distilled water for measurement of the Zeta potential at pH 7. 
Subsequently, a KOH solution in water was added to the sample to raise the pH to 9.5 
before the Zeta potential was measured again. 
Quantum Yield Measurements 
The absorbance and emission spectra of a series of dilutions of QDs were 
measured using an Ultrospec 2100 pro UV-Vis Spectrophotometer and a Tecan Safire2 
multiplate reader (Männedorf, Switzerland), respectively. The QD quantum yields were 
measured against rhodamine 6G in water. 
The integrated emission was plotted against the peak absorbance for each of the 
dilutions of the QDs and rhodamine. The data points for each were fitted to a line and the 
























η , (2) 
where the subscripts QD and R stand for the QDs and rhodamine, Φ is the fluorescence 
quantum yield, Slope is the slope of the linear fit of the integrated emission versus 
absorbance, and η is the refractive index of the solvent, which was assumed to be 1.33 for 
both the QDs and rhodamine. 
Quantum Dot Stability Assay 
Quantum dot stock solutions were diluted into either 10 mM tetraborate buffered 
saline, pH 9.5, or 10 mM tetraborate buffer with 1 M NaCl, pH 9.5, to a concentration 
between 100 and 200 nM in 384 well flat-bottomed, black well plates. The fluorescence 
emission spectra were measured in a Tecan Safire2 with 400 nm excitation as soon as 
feasible and every ten minutes thereafter for a total of 50 measurements. The 
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photoluminescence intensity at its peak wavelength was normalized to the maximum 
intensity for that QD and buffer condition and plotted versus time to see how the 
fluorescence of that nanoparticle changed with time in the assay conditions used for the 
study described in Chapter 5. 
Spectral Overlap and Förster Distance Calculations 
Igor software was used as previously described (4, 104) to calculate the overlap 
integral and Förster distance for each of the possible FRET pairs. The spectral overlap 
integral: 
 λλλελ dFJ AD
4)()(∫=  (3) 
describes the degree of coincidence between the donor emission and the acceptor 
absorption, where FD is the normalized emission spectrum of the donor, εA is the molar 
extinction coefficient of the acceptor, and λ is the wavelength in nanometers (4). Once the 
overlap integral was calculated, the Förster distance (R0), the distance between the donor 









where κ2 is the dipole orientation factor, assumed to be ⅔, QD is the quantum yield of the 
donor, and nr is the refractive index of the medium (4). 
FRET Assay Protocol (Chapter 5) 
Assays assessing the binding of His-tagged mCherry to diverse QDs were 
conducted by measuring the FRET efficiency of the various pairs in black, flat-bottomed, 
non-binding 384-well plates (Corning). QDs and FPs were mixed directly in the well 
plates with a final QD concentration of 50 nM and 1 to 12 molar equivalents of protein 
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per QD in either 10 mM tetraborate buffered saline, pH 9.5 or 10 mM tetraborate buffer, 
1M NaCl, pH 9.5, as indicated. After allowing at least 15 minutes for self-assembly, the 
emission spectra of the FRET pairs were measured in a Tecan Safire2 multiplate reader 
with an excitation wavelength of 400 nm, excitation bandwidth of 10 nm, emission 
bandwidth of 5 nm, integration time of 100 µs, and a stepsize of 2 nm. All of the assays 
were performed in triplicate, as were FP-only controls.  
For QD-FP binding studies involving Ni2+, the FRET pairs were measured first 
with just the QDs and FPs present, then 1 µL of 20 mM NiCl2 was added to the 80 µL 
reaction volume, resulting in a final Ni2+ concentration around 250 µM. The solutions 
were incubated at room temperature for at least fifteen minutes to allow binding to reach 
a steady state and then the emission spectra were measured in the Tecan Safire2 
multiplate reader. 
Modified FRET Assay (Chapter 5) 
Both the DHLA QDs and carboxyl-functionalized EviTags were utilized in an 
alternative FRET assay, where the number of fluorescent protein acceptors was varied, 
but the same total number of His-tagged proteins was maintained in each reaction well. 
The DHLA QDs were incubated with a total of twelve proteins per QD, with either His5-
MBP or His6-mCherry-NF making up the balance between the number of His6-mCherry 
molecules and the total number of proteins per QD. The carboxyl-functionalized EviTags 




FRET Assay Protocol (Chapter 6) 
Alternating serial dilutions of the acceptor molecule were made in 384 well plates 
to produce a range of average QD:FP ratios ranging from 16 FPs per QD to fewer than 
0.2 FPs per QD. EviTag QDs were then added to the wells at final concentration of 50 
nM. All of the assays were prepared in PBS, pH 7.4, with 1% BSA added to minimize 
non-specific binding. After a 15 minute incubation to allow for self-assembly, the 
emission spectra were measured in a Tecan Safire multiplate reader with an excitation 
wavelength of 400 nm, excitation bandwidth of 12 nm, emission bandwidth of 5 nm, and 
a stepsize of 3 nm. Assays were performed using His-tagged fluorescent proteins, non-
His-tagged fluorescent proteins, and a His10 polypeptide. All of the assays were 
performed in triplicate, as were FP-only controls. 
FRET Assay Analysis 
Prior to analysis, the FRET spectra were corrected for any background emission 
due to the direct excitation of the acceptor, autofluorescence of the buffer (particularly 
when the buffer contained BSA), and detector noise. To this end, the emission spectra 
from the FP-only control wells were subtracted from each of the FRET spectra at the 
same FP concentration. Each background-subtracted spectrum was then deconvolved 
using PeakFit (v.4.12, Systat, San Jose, CA); the symmetrical EviTag emission was fitted 
to a Voigt Area peak, while an exponentially modified Gaussian (EMG) curve was used 
to account for the tailing seen in the asymmetrical FP emission. The areas under the QD 
peaks with FRET were normalized by the area under the QD spectrum in the absence of 













where FDA is the fluorescence of the donor in the presence of the acceptor and FD is the 
fluorescence of the donor in the absence of the acceptor (4). 
Curve-fitting 








where [Q] is the quencher concentration, and KSV is the Stern-Volmer quenching 
coefficient. 
In order to estimate the strength of binding between the EviTags and the His-
tagged proteins under steady-state conditions, the His6- and His10-FP data were fitted to 

















relates the fraction of ligand binding sites filled (θ) to the ligand concentration I, the 
dissociation constant or ligand concentration at which 50% of the binding sites are filled 
(KD), and the Hill coefficient (h). Several assumptions were made to adapt this equation 
for the current application. First, the number of ligand binding sites filled is not being 
measured, but rather the fluorescence emission of the QD in the presence of the ligand, 
i.e. the fluorescent protein. Because the fluorescence does not change uniformly 
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regardless of the ligand used, but rather depends on the effectiveness of the donor-
acceptor pair being studied, the FRET efficiency (Emax) of the pair is included in the 
expression. Also, because the fluorescence decreases with increased binding, the 
expression is subtracted from the maximum possible value, which for the normalized 
fluorescence is unity. These changes result in the expression: 




















where FDA is the fluorescence of the donor in the presence of the acceptor, FD is the 
fluorescence of the donor in the absence of the acceptor, and Emax is the maximum FRET 
efficiency (106). In this case, the nominal KD is not the concentration at which there is 
50% binding, but rather the concentration at which there is 50% quenching of the QD. 
The two are distinct because the fluorescent quenching is not linearly related to the 
number of acceptors bound (4, 10).  
Calculation of Donor-Acceptor Distance 
Using the FRET efficiencies determined for each QD:FP ratio and the Förster 
distance (R0) calculated for each FRET pair, the distance between the donor and the 
acceptor, R, was estimated using an equation that takes into account the binding of 
multiple acceptor FPs to each donor QD. The equation used for the FRET efficiency as a 













For any given ratio of donors to acceptors (or average number of acceptors per 
donor), the specific number of acceptors, k, attached to the donors is described by a 









The efficiency of the FRET interaction can be more accurately calculated for each donor-
acceptor ratio using a weighted distribution of efficiencies, taking into account the effect 




















We used Mathematica (v.6.0.1, Wolfram Research, Inc., Champaign, IL) to solve this 
equation for R for each value of n for each FRET pair.  
pH Sensor Bioconjugation 
Various fluorescent protein variants were covalently coupled to Invitrogen 525 
nm ITK Carboxyl Qdots using standard carbodiimide chemistry (61). The 8 µM Qdot 
stock solutions were diluted 1:10 in 10 mM borate buffer, pH 7.4, with a 40-fold molar 
excess of protein and 1,500-fold molar excess of EDC. The reaction mixture was 
protected from light and incubated overnight at 4˚C. Excess EDC and unbound protein 
was removed using a centrifugal filtration device with 100 kDa molecular weight cutoff 
(Microcon Ultracel YM-100, Millipore) at 1000 rcf. This procedure was applied to make 
probes with His6-mOrange, His6-mOrange M163K, and His6-mCherry-NF. 
The Beer-Lambert Law:  
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 lcA ⋅⋅= ε , (12) 
where A is the absorbance, ε is the molar extinction coefficienct (M-1 cm-1) and l is the 
pathlength of the cuvette (cm), was used to determine the probe concentration using the 
Qdot ε405 nm of 360,000 M-1 cm-1 (Invitrogen product data sheet). For probes containing 
fluorescent proteins (excludes probes made with mCherry-NF variants), the degree of 
conjugation was determined by comparing the absorbance spectra of the probe to the 
absorbance profile of unconjugated Qdots. By subtracting the Qdot spectra from the 
probe spectra, the spectra of the conjugated protein could be isolated. The Beer-Lambert 
Law was used to determine the number of proteins per Qdot using the measured molar 
extinction coefficients (see below). 
pH Titrations of mOrange, QDs, and FRET Probe 
mOrange and mOrange M163K were analyzed for their spectral properties in 
response to changes in the solution pH, as were their QD-conjugated probes. For 
absorption, fluorescence excitation, and fluorescence emission spectroscopy, the proteins 
were diluted in 20 mM phosphate buffered saline with 1% (w/v) BSA, pH 10.0. The BSA 
served to block protein adsorption to the cuvette surfaces. This precaution was found to 
be important because adsorption profiles could vary with pH, introducing error into the 
measurements.  
Titrations were performed by adding small, regular volumes of 1 N HCl to the 
buffer and mixing thoroughly. This procedure was first performed on the buffer and the 
pH measured with a pH meter (Orion perpHect LogR meter model 310) and the 
appropriate volumes of acid to be added were determined to ensure regular spacing of the 
measurements. Absorbance spectra were measured on the Ultrospec 2100 pro UV/Visible 
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Spectrophotometer with 1 nm step sizes. Excitation spectra with 5 nm stepsize were 
measured on a Horiba Jobin Yvon Fluorolog-3 Spectrofluorometer with 1 nm excitation 
bandwidth and 5 nm emission bandwidth at 585nm. Emission spectra were measured 
with 1 nm excitation bandwidth at 525 nm and 3 nm emission bandwidth and a 5 nm step 
size. 
Molar extinction coefficients for mOrange and mOrange M163K were extracted 
using the absorption spectra and the Beer-Lambert law. For the sake of obtaining the 
most accurate concentration measurement of the proteins possible for use in the molar 
extinction coefficient determination, protein samples were sent to the W. M. Keck 
Foundation Biotechnology Resource Laboratory at Yale University for amino acid 
analysis. There the protein samples were hydrolyzed and analyzed on a Hitachi amino 
acid analyzer. The protein concentrations were back-calculated from the nanomoles of 





CHAPTER 5  
SURFACE-LIGAND EFFECTS ON METAL-AFFINITY COORDINATION TO 
QUANTUM DOTS: IMPLICATIONS FOR NANOPROBE SELF-ASSEMBLY* 
INTRODUCTION 
The integration of biomolecules and inorganic nanocrystals into functional 
devices is a core requirement for future advances in nanobiotechnology. By developing 
protocols that yield better understanding and, ultimately, control of the construction of 
these hybrid devices, we will be able to design nanoparticle-based imaging probes and 
delivery systems in a much more concerted and deliberate manner.  
Assembly of biomolecule-QD constructs has proven to be a challenge even as 
orthogonal bioconjugation techniques become available (61). An optimal bioconjugation 
strategy would be quick and facile with high affinity, would not require subsequent 
purification, and would enable control of the molar ratios of the component parts, all 
while not disrupting the biological function of the biomolecule. Standard protocols 
include chemical coupling with covalent bonds (61), non-covalent interactions exploiting 
ligand-receptor affinities such as biotin-avidin binding (71), and more general affinity-
driven self-assemblies using electrostatic interactions (46, 108) or metal chelation (10, 
15, 78, 80-82). Each of these techniques has advantages and disadvantages, which must 
be assessed when choosing the bioconjugation method for a particular design of the 
biomolecule-QD construct.  
                                                 
* Modified from Dennis AM, Sotto D, Mei BC, Medintz IL, Mattoussi H and G Bao. 
Surface Ligand Effects on Metal-Affinity Coordination to Quantum Dots: Implications 
for Nanoprobe Self-Assembly, in preparation. 
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Covalent coupling provides the most durable attachment of a biomolecule to a QD 
with carbodiimide (EDC) chemistry being the most commonly utilized. However, this 
often causes nanoparticle aggregation, may result in a relatively low number of 
biomolecules per nanoparticle compared to the reaction ratios, and often requires 
purification steps that are also a source of loss, depressing the overall yield of the 
functional construct (61). In addition, the heterogeneous conjugation may cause proteins 
to attach in an unproductive manner or to lose activity. 
 Streptavidin-biotin binding is another common and useful coupling mechanism 
that utilizes exceptionally simple protocols, provided the constituent components are 
already functionalized with the required streptavidin and biotin moieties. With 
femptomolar binding affinities, the streptavidin-biotin interaction is often considered to 
be effectively as stable as a covalent bond (68). In some applications, however, the 
advantages of the streptavidin-biotin interaction may be overshadowed by the tetrameric 
nature of streptavidin, which can result in undesired multiple binding events and induce 
aggregation (73). With a molecular weight of ca. 53 kD, the addition of multiple 
streptavidin molecules to a single QD adds considerably to the overall size of the 
nanoparticle construct. This extra protein bulk could be detrimental in applications where 
the increase in size may impair function. Optical biosensors based on fluorescence 
resonance energy transfer (FRET), for example, require short distances between their 
fluorescent donors and acceptors. As the efficiency of energy transfer is inversely related 
to the donor-acceptor distance to the sixth power (4), the additional separation by a few 
nanometers due to the size of streptavidin can dramatically reduce FRET efficiency.  
55 
 
An alternative assembly option derives from the affinities between biomolecular 
components and various substrates. These range in strength and specificity from 
electrostatic interactions to metal chelation to interactions culled from phage display. 
Although the binding affinities of these reactions cannot rival that of avidin-biotin, 
advantages arise because the minimal affinity tag can often be naturally incorporated into 
the biomolecule of interest and bind to the QD without necessitating additional 
functionalization of the nanoparticle. Self-assembly based coupling requires only small 
tags, is facile, is typically not intrusive on the other components of the nanoparticle 
system, is orthogonal to most biological structures and activity, provides reasonable 
control over the relative component stoichiometries, and utilizes well-established 
protocols. As this fulfills many of the characteristics of ideal nanoparticle bioconjugation 
chemistry, it is thus highly desirable. 
A specific example of one such small affinity tag is the polyhistidine sequence 
(His-tag), which has an affinity for divalent cations. It was discovered that His-tag 
chelation of metal ions, such as Ni2+, Zn2+, or Cu2+, could be used to purify recombinant 
proteins using immobilized metal affinity chromatography (IMAC) (79). More recently, 
His-tags have been used to bind biomolecules, including proteins, peptides, and even His-
modified DNA, to QDs displaying zinc ions on their surface in the form of the ZnS 
capping layer of the CdSe/ZnS core-shell nanoparticles (10, 15, 78, 80-82). Although this 
coupling technique has been used with success in several QD-based sensing applications, 
the characteristics of the QD-polyhisitidine interaction appear to vary depending on the 
particular organic coating used to confer water solubility of the QDs (83).  
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In this chapter, a fluorescence resonance energy transfer (FRET) assay was 
developed and implemented to study the self-assembly of polyhistidine-tagged 
fluorescent proteins (FPs) and semiconductor quantum dots (QDs). QDs with eight 
different organic coatings from three distinct sources were evaluated using the FRET 
assay to determine their capacity for self-assembly. The three major categories of QDs 
consist of (1) QDs coated using ligand exchange with DHLA, DHLA-PEG600-OH 
(DHLA-PEG), or DHLA-PEG750-OCH3 (DHLA-mPEG); (2) Invitrogen Qdots, which are 
coated with an amphiphilic block co-polymer, including  carboxyl Qdots and amino-PEG 
Qdots; and (3) lipid-PEG coated QDs, specifically carboxyl-functionalized, amine-
 
Figure 5.1: FRET-based assessment of QD-FP self-assembly. 
Schematic of the FRET assay used to investigate the His-tag self-assembly on quantum 
dots. An N-terminal polyhistidine sequence is used to assemble mCherry (PDB 2H5Q) on 
the surface of the quantum dot. If assembly is successful, the proximity of the QD and FP 
will facilitate energy transfer and a measurable FRET signal will be detected. 
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functionalized, and non-functionalized EviTags (Evident Technologies). In order to relate 
the results of the FRET assay to the fundamentals of the interaction between the His-
tagged fluorescent protein and the QD, basic QD properties, such as core-shell size, 
hydrodynamic diameter, zeta potential, quantum yield (QY), and photoluminescence (PL) 
stability, were first characterized and compared. The advantages and disadvantages of 
using each QD coating scheme in nanoprobe self-assembly are discussed. The outcomes 







A non-fluorescent, non-chromogenic GFP-like protein was developed as a control 
for the effect of His-tag binding on QDs by introducing three point mutations (S144C 
I161N Q163M) into mCherry to produce His6-mCherry-NF. Circular dichroism (CD) 
was used to verify the structural similarities with respect to protein folding and secondary 
structure formation between the proteins His6-mCherry and His6-mCherry-NF. The two 
CD spectra overlap nicely (Figure 5.2) with minima below 220 nm, which is 
characteristic of the beta sheets that make up the barrel structure of all GFP-like proteins 
(Figure 5.2, inset) (97, 109). 
Absorbance and emission measurements (with excitation at 560 nm) of 10 µM 
 
Figure 5.2: CD spectra of His6-mCherry and His6-mCherry-NF. 
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(28 µg/mL) solutions of the two proteins were made on a Tecan Safire2 multiplate reader. 
His6-mCherry-NF showed no capacity for either absorbance or emission in the visible 
wavelength range (Figure 5.3). The emission of His6-mCherry-NF remained flat even 
with greatly increased detector sensitivity (data not shown). 
 
 
Figure 5.3: Spectral properties of His6-mCherry and His6-mCherry-NF. 
Absorbance (top) and emission (bottom) spectra of His6-mCherry and His6-mCherry-NF. 
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Quantum Dot Properties 
Transmission electron microscopy (TEM) images verified that the core-shell sizes 
of the CdSe/ZnS QDs studied were all approximately 5 nm in diameter regardless of the 
material source (data not shown). Significant differences in the hydrodynamic diameter 
were, however, apparent in dynamic light scattering (DLS) measurements (Table 5.1), 
which reflect the effect of the hydrated organic coating on the particle dimensions in 
solution.  
The hydrodynamic diameter of the three ligand exchange-coated QDs varied as 
expected with the presence and length of the PEG moiety, ranging from 9.8 to 12.9 nm. 
All three varieties originated from the same batch of core-shell QDs and had quantum 
yields between 0.10 and 0.12 (Table 5.1). 
The amphiphilic block co-polymer coated carboxyl Qdots from Invitrogen 
exhibited the smallest hydrodynamic diameter (13 nm) of the commercially available 
QDs (Table 5.1). The amine-terminated PEG2000 chains are conjugated to the carboxyl 
Qdots to produce amino-PEG Qdots, adding almost 3 nm to the hydrodynamic diameter 
of the carboxyl Qdots (Table 5.1). Both of these QD varieties have QYs above 0.7. 
Table 5.1: Summary of quantum dot properties. 




at pH 7 (mV)c 
Zeta Potential 




Lipid-PEG-COOH 0.29 14.9 ± 1.7 -0.6 ± 0.2 -26.5 ± 0.8 
Lipid-PEG-NH2 0.77 20.8 ± 0.5 -4.0 ± 0.6 -31.8 ± 0.5 
Lipid-PEG-OCH3 0.39 23.2 ± 0.7 -10.0 ± 0.5 -15.5 ± 1.3 
Invitrogen: 
Qdot 545 ITK 
Polymer (-COOH ) 0.75 13.0 ± 0.3 -3.4 ± 0.8 -31.0 ± 1.3 




DHLA 0.11 9.8 ± 0.3 -29.8 ± 1.8 -23.3 ± 2.6 
DHLA-PEG600-OH 0.10 12.2 ± 0.9 -12.9 ± 1.3 -34.6 ± 2.0 
DHLA-PEG750-OCH3 0.12 12.9 ± 0.5 -2.8 ± 0.5 -182 ± 0.6 
a QY measured relative to Rhodamine 6G in water. 
bHydrodynamic diameter values are the mean ± standard deviation of the volume-weighted size distribution. 




With an average hydrodynamic diameter of 23.2 nm, the non-functionalized T2-
MP EviTags were the bulkiest among the eight types of QDs studied (Table 5.1). 
Although the amine-functionalized EviTags merely substituted an –NH2 for the –OCH3 
terminal group on the non-functionalized EviTags, their hydrodynamic diameter was 
reduced to 20.8 nm. Changing the terminal functional group to –COOH further reduced 
the hydrodynamic diameter of the carboxyl-functionalized EviTag to 14.9 nm (Table 
5.1). The lipid-PEG coated QDs showed significant batch-to-batch variations in their 
QYs, with measured values ranging from 0.29 to 0.77. 
Quantum Dot Stability 
All of the DHLA-coated QDs exhibited an approximately 20% decrease in 
photoluminescence (PL) in the first several readings after being dispersed in 10 mM 
tetraborate buffered saline, pH 9.5 (Figure 5.4). While the PEGylated QDs recovered 
their initial PL intensity, the QDs coated with only DHLA did not recover, but did reach a 
stasis where the PL was much better maintained from one measurement to the next. All 
three of the QD types showed slow, but steady, declines in the PL intensity with time. 
Under high salt conditions (10 mM tetraborate buffer, 1 M NaCl, pH 9.5), the PEGylated 
QDs did not show the same PL recovery seen in saline, but were stable enough to exhibit 
only a very gradual decrease in PL intensity with time once equilibrium was reached. The 
QDs coated with only DHLA, in contrast, were not stable in the high salt conditions and 
demonstrated a dramatic decrease in PL over time. 
The PL of Qdots from Invitrogen also showed instability immediately following 
dilution into the buffers (Figure 5.5). Although the carboxyl Qdot showed a much larger 
decrease in PL in the first few measurements than the amino-PEG Qdots, there were not 
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dramatic differences between the saline and high salt conditions for either Qdot, although 
the high salt reduced the rate of PL decline in both cases.  
All of the EviTags dropped 30 – 40% of their PL in the first few measurements 
before achieving a certain level of PL stability (Figure 5.6). No significant differences 
were seen based on coating functionality or buffer conditions.  
The PLs were erratic for the first 10% of the stability measurements by time, but 
thereafter the data points could be fit to a line. The value of that slope was graphed in 
Figure 5.7 to summarize the differences in the rate of PL change for all of the QDs and 
buffer conditions. Six of the eight QDs (excepting the DHLA QDs and carboxyl-
functionalized EviTags) displayed a less steep slope in the high salt conditions than in 
buffered saline. This may indicate that the high salt content reduces electrostatic 
interactions with the vessel surfaces, thereby preventing adsorption of particles to the 
well plate walls. 
 












Calculations of the overlap integral and Förster distance for each of the FRET 
pairs, as well as the FRET efficiency observed at a 1:1 ratio of donors to acceptors and 
the maximum FRET efficiency observed for each donor-acceptor pair is summarized in 
Table 5.2. 
Our FRET assays revealed that, of the three DHLA-based organic coatings, only 
QDs coated with DHLA itself demonstrated a significant capacity for self-assembly via 
polyhistidine coordination (Figure 5.8). The spectra plots of the DHLA incubated with 
 
Figure 5.7: Magnitude of the slopes of the stability plots. 
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His6-mCherry show a decrease in the QD emission with a concomitant dose-dependent 
increase in the sensitized emission of the fluorescent protein with a clear isosbestic point 
around 580 nm (Figure 5.8, top). It was not possible to test the DHLA QDs under high 
salt conditions because the electrostatically stabilized QDs were not stable in that buffer 
(Figure 5.4), but the addition of the divalent cation (Ni2+) did not seem to further enhance 
the interaction between the FPs and the quantum dot (Figure 5.8, bottom). Both PEG-
conjugated DHLA moieties exhibited minimal quenching of the QD emission and 
negligible sensitized emission from His6-mCherry (Figure 5.9 and Figure 5.10).  
The carboxyl Qdots from Invitrogen showed only a limited capacity as a FRET 
donor to the His6-tagged mCherry in borate buffered saline, and this subtle interaction 
was disrupted in the presence of 1 M NaCl (Figure 5.11). However, a stronger FRET 
signal was observed following supplementation with NiCl2. The Ni2+-dependent FRET 
signal was also reduced in the presence of 1 M NaCl, but not eliminated as in the non-
Ni2+-dependent case (Figure 5.12). The amino-PEG ITK Qdots showed no difference in 
QD emission regardless of whether His-tagged or control mCherry was used (Figure 




(10-15 M-1 cm3) R0 (Å) 
E at 1:1 
QD:FP max E 
Carboxyl-functionalized 540 nm T2-MP 
EviTag 4.77 52.6 0.51 0.76 
Amine-functionalized 540 nm T2-MP EviTag 3.82 59.6 0.37 0.64 
Non-functionalized 540 nm T2-MP EviTag 4.20 53.9 N/A N/A 
Qdot® 545 ITK™ carboxyl quantum dots 4.56 61.1 <0.01 (0.09)a 
0.21 
(0.47)a 
Qdot® 545 ITK™ amino (PEG) quantum dots 5.10 62.1 N/A N/A 
DHLA 550 nm QDs 4.73 44.9 0.15 0.48 
DHLA-PEG 550 nm QDs 4.57 43.8 0.02 0.18 
DHLA-mPEG 550 nm QDs 4.76 45.2 0.01 0.17 




5.13). The addition of NiCl2 to the reaction buffer did not increase the level of interaction 
between the amino-PEG Qdot and His6-mCherry (Figure 5.14).  
The carboxyl-functionalized EviTags were shown to be excellent FRET donors 
with 70% quenching of the QD emission at a donor to acceptor ratio of 1:3 (Figure 5.15). 
This interaction was relatively unchanged in the presence of 1M NaCl. Amine-
functionalized EviTags also demonstrated a capacity for the polyhistidine-mediated self-
assembly (Figure 5.16), but this interaction was more susceptible to disruption from high 
salt concentrations. Using the FRET assay, we found that the non-functionalized EviTags 







Figure 5.8: Self-assembly to DHLA QDs. 
Top: Spectra of DHLA QDs incubated with varying ratios (N) of His6-mCherry 
monomers per QD. Bottom: Graph of the normalized QD emission relative to the number 







Figure 5.9: Self-assembly to DHLA-PEG QDs. 
Top: Spectra of DHLA-PEG QDs incubated with varying ratios (N) of His6-mCherry 
monomers per QD. Bottom: Graph of the normalized QD emission relative to the number 







Figure 5.10: Self-assembly to DHLA-mPEG QDs. 
Top: Spectra of DHLA-mPEG QDs incubated with varying ratios (N) of His6-mCherry 
monomers per QD. Bottom: Graph of the normalized QD emission relative to the number 







Figure 5.11: Self-assembly to carboxyl Qdots. 
Top: Spectra of carboxyl Qdots incubated with varying ratios (N) of His6-mCherry 
monomers per QD. Bottom: Graph of the normalized QD emission relative to the number 







Figure 5.12: Self-assembly to carboxyl Qdots with Ni2+ supplementation. 
Top: Spectra of carboxyl Qdots incubated with varying ratios (N) of His6-mCherry 
monomers per QD after addition of NiCl2. Bottom: Graph of the normalized QD emission 
relative to the number of acceptor molecules per QD. All points are mean ± standard 







Figure 5.13: Self-assembly to amino-PEG Qdot. 
Top: Spectra of amino-PEG Qdots incubated with varying ratios (N) of His6-mCherry 
monomers per QD. Bottom: Graph of the normalized QD emission relative to the number 







Figure 5.14: Self-assembly to amino-PEG Qdots with Ni2+ supplementation. 
Top: Spectra of amino-PEG Qdots incubated with varying ratios (N) of His6-mCherry 
monomers per QD after addition of NiCl2. Bottom: Graph of the normalized QD emission 
relative to the number of acceptor molecules per QD. All points are mean ± standard 







Figure 5.15: Self-assembly to carboxyl-functionalized EviTags. 
Top: Spectra of carboxyl-functionalized EviTags incubated with varying ratios (N) of 
His6-mCherry monomers per QD. Bottom: Graph of the normalized QD emission 
relative to the number of acceptor molecules per QD. All points are mean ± standard 







Figure 5.16: Self-assembly to amine-functionalized EviTags. 
Top: Spectra of amine-functionalized EviTags incubated with varying ratios (N) of His6-
mCherry monomers per QD. Bottom: Graph of the normalized QD emission relative to 
the number of acceptor molecules per QD. All points are mean ± standard deviation with 







Figure 5.17: Self-assembly to non-functional EviTags. 
Top: Spectra of non-functionalized EviTags incubated with varying ratios (N) of His6-
mCherry monomers per QD. Bottom: Graph of the normalized QD emission relative to 
the number of acceptor molecules per QD. All points are mean ± standard deviation with 
n = 3. 
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Modified FRET Assay 
As changes in the QD environment may affect the brightness of the QD, any 
change in the QD photoluminescence as a result of His-tag binding is of general 
importance when using this self-assembly method, particularly in FRET assays. As has 
been previously documented (11), the polyhistidine-mediated coordination of a non-
fluorescent protein such as maltose-binding protein (MBP) to the DHLA-coated QDs 
results in a photoluminescence increase of up to 20%. This was attributed to the filling of 
surface defects in the DHLA coating by His-tags, thereby reducing the emission loss. 
This effect could be problematic for the analysis of the FRET assays described above, 
since His-tag binding increases the QD emission concomitantly as the QD emission is 
being reduced by energy transfer to the His6-mCherry proteins. This concern was 
mitigated, however, by using a modified FRET assay, consisting of incubating the QDs 
with a fixed number of His-tagged proteins while varying the ratio of fluorescently-
labeled proteins to non-fluorescent His5-MBP proteins (11). This alternative assay 
resulted in an increased FRET efficiency compared to the standard protocol where the 
non-fluorescent His-tagged protein is not present in the reaction. 
Both the His5-MBP that has previously been used (11) and a non-fluorescent, 
non-chromogenic GFP-like protein were tested for their effect on the QDs. The His5-
MBP was used for comparison to the results seen previously, while the new GFP-like 
protein was engineered using a series of three point mutations to mCherry (S144C I161N 
Q163M) to create a protein that is structurally analogous to mCherry, but would not by 
itself affect the photoluminescence of the QDs as it neither absorbs nor emits light at 
visible wavelengths. The use of a protein that is structurally identical to mCherry, while 
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not exhibiting the optical properties that affect the QD, provides a control for the ways in 
which environmental changes, such as His-tag binding or the presence of a protein 
corona, could affect the QD PL. 
Most of the QDs were relatively unaffected by the presence of the non-fluorescent 
His-tagged proteins (Figure 5.18). Both the DHLA-coated QDs and carboxyl-
functionalized EviTags, however, demonstrated a small increase in photoluminescence in 
the presence of His-tagged proteins, although it was not reliably dose-dependent. This 
increase in QD PL may indicate that both the DHLA QDs and carboxyl-functionalized 
EviTags have defects in their organic coatings that reduce their quantum yields in the 
aqueous environment.  
In order to account for the small increase seen in the PL of these two QDs upon 
binding of a non-fluorescent His-tagged protein, a modified FRET assay was performed 
in which the total number of proteins in the solution was maintained, but the ratio of 
fluorescent to non-fluorescent proteins was varied. DHLA-coated QDs were incubated 
with a total of 12 proteins per QD: the total number of His6-mCherry molecules was 
increased with corresponding decreases in either His6-mCherry-NF or His5-MBP. There 
was not a dramatic difference between the experiments using His6-mCherry-NF or His5-
MBP, but the shape of those two quenching curves was distinct from that of the DHLA-
coated QDs incubated with His6-mCherry in the absence of any filler proteins (Figure 
5.19, top). The carboxyl-functionalized EviTags were likewise incubated with a mix of 
His6-mCherry-NF and His6-mCherry, but in this case the total number of proteins in 
solution was limited to six per QD. The carboxyl-functionalized EviTags exhibited the 
same quenching profile with or without the His6-mCherry-NF filler proteins present 
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(Figure 5.19, bottom), but at each FP:QD ratio there was slightly less quenching in the 




Figure 5.18: Effect of His-tag binding on quantum dot photoluminescence. 
Relative emission of QDs incubated with varying concentrations of either His5-MBP 






Figure 5.19: Results of modified FRET assay. 
Effect of using a mixture of fluorescence and non-fuorescent proteins in FRET assay on 
DHLA-coated (top) and carboxyl-functionalaliezed EviTags (bottom). All points are 
mean ± standard deviation with n = 3. 
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The differences between the results from the standard FRET assay and the 
modified FRET assay did not appear to improve energy transfer sufficiently to warrant 
the change in protocol. It is possible that the non-fluorescent proteins proved to be 
competition for binding on the QD surface, thereby mitigating the positive effect that 
could have been seen by enhancing the QD PL.  
Donor-Acceptor Distance Calculations 
As described in the Methods (page 49), the donor-acceptor distance was 
calculated taking into account the fact that multiple acceptors may be bound to each 
donor molecule. The donor-acceptor distances were calculated both using the standard 
equation for multivalent systems (Equation (9), page 49), which uses the average number 
of donors per acceptor, and using an equation where the Poisson distribution of acceptors 
per donor was taken into account (Equation (11), page 50). 
The calculated donor-acceptor distances for the four conditions in which 
calculating a donor-acceptor distance was the most relevant are listed in Table 5.3. While 
the trends are the same whether the Poisson distribution was used or not, significant 
differences in the resulting donor-acceptor distances were apparent in cases where 
significant FRET efficiencies were observed at low acceptor to donor ratios. This 
discrepancy, which is the most dramatic for the carboxyl-functionalized EviTags, is due 
to the underestimation of the donor-acceptor distance that occurs at low acceptor to donor 
ratios when the Poisson distribution is not taken into account. Errors of up to 40% have 
been described as theoretically possible at 1:1 acceptor to donor ratios (107). 
83 
 












FP:QDb +c -d + - + - FP:QD + - 
0.25 69.6 64.5 52.4 35.5 59.8 57.9 0.167 82.4 80.0 
0.5 66.0 59.6 52.3 39.6 57.2 55.0 0.334 99.7 98.8 
0.75 65.5 59.4 52.3 42.1 57.3 55.2 0.5 126.7 126.4 
1 65.0 59.3 52.4 43.9 60.1 58.4 0.668 95.0 93.9 
1.5 66.5 62.2 53.2 47.3 56.8 54.9 1 90.5 89.2 
2 68.4 65.0 53.8 49.3 57.8 56.1 1.336 86.6 84.9 
3 70.6 68.1 55.2 52.2 58.8 57.4 3 91.1 90.0 
4 72.2 70.3 56.9 54.7 59.2 58.0 4 92.9 91.9 
6 75.5 74.1 59.3 57.8 62.0 61.2 6 94.2 93.3 
8 77.7 76.6 62.3 61.2 64.3 63.6 8 95.1 94.4 
12 82.1 80.8 65.7 64.3 69.8 69.0 12 97.3 96.2 
Min 65.0 59.3 52.3 35.5 56.8 54.9 
 
82.4 80.0 
Max 82.1 80.8 65.7 64.3 69.8 69.0 
 
126.7 126.4 
Mean 70.8 67.35 56.0 49.8 60.3 58.8 
 
95.6 94.5 
Median 69.6 65.0 53.8 49.3 59.2 57.9 
 
94.2 93.3 
a All distance values reported are in angstroms (Å). 
b The mixing ratio of acceptor to donor molecules. 
c Calculation of the donor-acceptor distance with application of the Poisson’s distribution. 





FRET assays were performed to determine under what conditions and to what 
extent the His-tag mediates self-assembly of fluorescent proteins to QDs in order to 
discern the effect that various QDs organic coatings have on self-assembly. The FRET-
based assay is particularly useful here because it both confirms the proximity of the 
nanoparticle and biomolecule and allows the derivation of a separation distance due to its 
distance dependence. This provides insight into both self-assembly and the overall 
conjugate structure. In all cases, a non-His-tagged fluorescent protein, mCherry, was used 
as a negative control in order to ascertain that the His-tag was necessary to induce the 
interaction between the donor and acceptor. When possible, assays were repeated under 
high salt conditions (1 M NaCl) in order to disrupt electrostatic interactions to 
demonstrate whether the interaction is metal chelation-based or mediated 
electrostatically. His-based metal chelation to immobilized metal (i.e. Ni-NTA) can 
tolerate extreme conditions including the presence of denaturing agents like 5% SDS, 6 
M guanidine, 8 M urea, and greater than 1 M NaCl (61, 78, 79). In addition, 
supplementation with Ni2+ was included to determine if the addition of a chelating ion 
could enhance the donor-acceptor interaction. 
Ligand Exchange-coated QDs 
Quantum Dot Properties. All three of the ligand exchange-coated QDs 
originated from the same batch of CdSe/ZnS QDs produced at high temperatures with 
organometallic precursors by our collaborators at the Naval Research Laboratories (NRL) 
in Washington, D.C. The coating procedure was the same for DHLA and the two DHLA-
PEG derivatives and produced QDs with very similar QYs. 
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All of the QDs tested have similar core-shell sizes, which is expected as emission 
wavelength is directly correlated to the core size (32), but the DHLA QD was the only 
one of the eight tested that exhibited a sub-10 nm hydrodynamic diameter. This small 
diameter is possible because the ligand-exchange method used to coat the QDs with 
DHLA-based moieties removes the TOP/TOPO surfactant that is present on the surface 
of the CdSe/ZnS core-shell following the QD synthesis (45, 46). DHLA binds to the ZnS 
capping layer via bidentate thiols and its deprotonated carboxylic acids hold the QD in 
suspension as a colloid. With a molecular weight of only 208 g/mole, DHLA is one of the 
smallest organic molecules capable of conferring water-solubility to the inorganic 
quantum dots (40). Although this ultra-thin organic coating is ideal for minimizing the 
donor-acceptor distance which is critical for achieving high FRET efficiencies, it comes 
with some caveats. First, the coating method decreases the QY of the QDs significantly 
relative to the starting QDs in organic solvents. In addition, the DHLA-coated QDs are 
further stabilized in aqueous solutions by their electrostatic repulsion of one another; 
thus, they are susceptible to changes in their colloidal stability depending on their 
environment and protonation state, i.e. pH, and are known to be more stable in alkaline 
solutions than at acidic pHs (45). Compared to the other seven QDs used in this study, the 
DHLA-coated QDs showed an accelerated decrease in photoluminescence over time 
when suspended in buffer containing 1 M NaCl. In contrast, the 25% and 32% increase in 
hydrodynamic diameter over the DHLA coating for the DHLA-PEG and DHLA-mPEG 
coated QDs, respectively, was accompanied by an increase in colloidal stability since 
solubility is mediated by the ethylene glycol repeats. These QDs also exhibited a more 
constant photoluminescent output over time, including under high salt conditions. 
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FRET Assay Results. The dose-dependent changes in the spectral profile of the 
DHLA-coated QDs mixed with His6-mCherry indicates that self-assembly proceeded 
under these conditions, confirming previous reports of His-tag-mediated self-assembly to 
DHLA-coated QDs (10, 11). The approximately 6 nm donor-acceptor distance calculated 
for the DHLA-coated QD and His6-mCherry does not give a clear indication of where the 
protein is positioned with respect to the organic coating, although it is clear that the FP 
barrel structure is very close to the QD core-shell surface. This is consistent with 
previously reported kinetic data on the binding of His-tagged biomolecules to DHLA-
coated QDs, which indicated that the His-tag binds directly to the ZnS capping layer of 
the QD (78). 
Both PEG-conjugated DHLA moieties exhibited minimal quenching of the QD 
emission and negligible sensitized emission from His6-mCherry, demonstrating an 
inability of the His-tag to stably interact with the nanoparticle with the steric hinderance 
from the PEG coating, despite the negative surface charges indicated by their zeta 
potentials. The steric hinderance provided by the PEG coatings on the DHLA-PEG and 
DHLA-mPEG QDs precluded those QDs from participating in self-assembly with His-
tagged proteins, despite the negative surface charges indicated by their zeta potentials. 
While this eliminates QDs coated with DHLA-PEG derivatives as an option for His-tag 
mediated self-assembly, the improvements in stability and environmental sensitivity 
recommend this coating for other applications, such as intracellular imaging (110). 
Polymer-coated QDs 
Quantum Dot Properties. The hydrophobic region of the amphiphilic 
poly(acrylic) acid polymer used to coat the Qdots interdigitates with the surfactant 
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residues on the surface of the QDs following the inorganic synthesis. The hydrophilic 
portion of the polymer presents a high density of carboxyl groups at the QD-solvent 
interface. Although the water solubility of the Qdots is also conferred by the presence of 
hydrophilic carboxylic acids, the larger, more neutral polymer (compared to the small 
molecule DHLA) does appear to improve the QD passivation as well, providing the Qdot 
with relatively constant photoluminescence over time, even in high salt conditions. This 
coating type also preserves the high QY of the QDs even in aqueous solution. These high 
quantum yields make the Qdots excellent FRET donors, as evidenced by the high Förster 
radii calculated for both the carboxyl and amino-PEG Qdots, but the larger hydrodynamic 
diameter of the Qdots could extend the donor-acceptor distance, lowering FRET 
efficiency. 
The amino-PEG Qdots add another layer to the same coating scheme used for the 
carboxyl Qdots. The amine-terminated PEG2000 that are conjugated to the carboxyl 
groups on the surface of the carboxyl Qdots provide an extreme hydration layer that 
results in a QD surface that significantly reduces non-specific interactions (57). 
It is interesting to note that in the stability assays, six of the eight QDs tested, 
including both of the Qdots, actually showed a slower rate of PL decrease in the high salt 
buffer. Perhaps the high ion concentration mitigated any electrostatic interactions that the 
nanoparticles would have had with the surface of the well plate, thereby reducing 
somewhat the non-specific adsorption of the QDs to the plate. 
FRET Assay Results. In the absence of supplemented Ni2+, we found that the 
interaction between the fluorescent protein and the carboxyl Qdot is a non-specific, 
electrostatically-mediated interaction that can be disrupted with high salt concentrations. 
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The supplemented Ni2+, however, appears to affiliate with the high density of carboxyl 
groups on the Qdot surface, enabling the interaction of the His-tag with the Qdot via Ni2+ 
chelation. The same interaction was observed in another study when His-tagged 
luciferase molecules were incubated with carboxyl Qdots in the presence of Ni2+ (85). 
Other divalent ions including Ca2+, Mg2+, and Mn2+ were tested in that study as well, but 
Ni2+ was the most effective one in inducing the interaction between the His-tagged 
protein and the Qdot, while maintaining protein functionality (85). Calculation of the 
corrected donor-acceptor distance yielded a median separation of 94 Å between the QD 
core and the FP fluorophore. This distance is significantly larger than the hydrodynamic 
radius of 65 Å measured for the QDs, and consistent with the model in which the FPs 
bind to the outer surface of a solid polymer coating that surrounds the QD core-shell. The 
presence of the amino-PEG moieties on the Qdot surface apparently shielded the 
nanoparticles from the non-specific electrostatic interactions seen with the carboxyl 
Qdots and, without the high-density of solvent-exposed carboxyl groups, the amino-PEG 
Qdot was unable to chelate Ni2+ ions from the solution to facilitate an interaction with 
His-tagged proteins. The zeta potential measurements showed that the carboxyl Qdots are 
highly negatively charged while the amino-PEG Qdots have a near neutral zeta potential, 
supporting the finding that the carboxyl Qdots are primed for both electrostatic 
interacqations and metal chelation whereas the amino-PEG Qdots are not. 
Lipid-PEG-coated QDs 
Quantum Dot Properties. The three EviTags exhibited rather different 
hydrodynamic diameters although they used the same core-shell structure and lipid-PEG 
coating scheme. These differences in the hydrodynamic diameter of the three EviTags 
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may indicate variations in the density and orientation of the lipid-PEG coating. A 
previous report on the thickness of DSPE-PEG2000 monolayers measured by neutron 
reflectivity of Langmuir-Blodgett films indicated that a densely packed monolayer of 
DSPE-PEG2000 could reach a thickness of 10.7 nm, but less densely packed monolayers 
demonstrated proportionally decreasing monolayer thicknesses. In that case, the decrease 
in the monolayer thickness was found to be related to the brush height of the PEG 
polymer; the lipid demonstrated no density-dependent variation in its geometry (111). 
This effect may be even more pronounced when the lipid-PEG is used to coat a 
nanoparticle, since the curvature of the particle inherently increases the surface volume 
available for the free movement of the PEG molecule even in densely packed coatings. 
Thus, it is possible that the lipid-PEG molecules of the non-functionalized EviTags are 
more densely packed, resulting in a brush-like configuration of the PEG chains, while 
amine-functionalized EviTags exhibit a more mushroom-like configuration, and the PEG 
strands in carboxyl-functionalized EviTags may relax into a pancake-like configuration 
due to a low packing density. Although it is unintuitive that just a couple of atoms at the 
extremity of the large lipid-PEG coating molecules could wield such influence on the 
packing density and structure of the entire coating layer, it is possible that charge 
repulsions of the amine and carboxyl functional groups could affect molecular 
interactions during the coating procedure. While the variation in coating thickness does 
not appear to affect PL stability of QDs, it does seem to influence polyhistidine self-
assembly, as discussed below. 
FRET Assay Results. When the EviTags were evaluated for their capacity for 
His-tag-mediated self-assembly, the interaction between the His6-mCherry and the 
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EviTags was found to be dependent on the functional group employed in the lipid-PEG 
coating. His-tag binding to carboxyl-functionalized EviTags proceeded in both saline and 
high salt and was not enhanced by the addition of Ni2+. This indicates that the interaction 
was neither electrostatically driven nor dependent on the chelation of free divalent cations 
by the carboxyl groups, as is the case with the carboxyl Qdots.  
The amine-functionalized EviTags also demonstrated a capacity for His-tag 
mediated binding, but the mechanism of the interaction is less clearly defined by the 
FRET results. Binding appeared to proceed similarly to that observed for the carboxyl-
functionalized EviTags in buffer containing saline, but the extent of QD quenching was 
lessened in the high salt buffer. In addition, the shape of the dose-dependent quenching 
curve was altered under high salt conditions as well, indicating that the mechanism of the 
interaction between the amine-functionalized EviTags and His6-mCherry likely contains 
an electrostatic component, where transient non-specific interactions between the amines 
in the coating and the fluorescent protein may provide the opportunity for close proximity 
between the His-tag and the QD surface. Although these non-specific associations do 
appear to contribute to the probe assembly in this case, steady-state binding is not solely 
reliant on the electrostatic attraction. 
There was no evidence of His-tag-mediated binding of the fluorescent protein to 
the non-functionalized EviTags in the FRET assay, indicating that this system is distinct 
from both the carboxyl- and amine-functionalized EviTags. 
The significant differences in the quenching effect of the three EviTag QDs is 
surprising given that the only difference between the three QD types is the functional 
group at the terminal end of the lipid-PEG coating moiety. However it may be explained, 
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in part, by the hydrodynamic diameter measurements. If the large diameter of the non-
functionalized EviTags is indeed indicative of a coating with closely packed lipid-PEG 
molecules that are extended brush-like, then this coating may be impenetrable to the His-
tagged FP. If the 35% decrease in the hydrodynamic diameter of the carboxyl-
functionalized EviTags, in contrast, indicates a less dense, or even patchy, lipid-PEG 
coating, then some regions of the QD surface may be exposed, thus amenable to the 
binding of the polyhistidine tag. It is unclear, however, what role the TOP/TOPO layer 
that passivated the surface following the inorganic synthesis plays in this scenario. The 
amine-functionalized EviTags exhibited a behavior between the two discussed above, 
both in hydrodynamic diameter and the extent of FRET. In fact, given the much higher 
quantum yield of the amine-functionalized EviTag, one would expect a greater quenching 
than that with the carboxyl-functionalized EviTag, if the same number of fluorescent 
proteins were bound to the QDs and were positioned at the same distance from the QD 
core. Instead, we found that quenching was reduced with the amine-functionalized 
EviTags. Calculations of the donor-acceptor distances using the Poisson distribution 
yielded median R values of 56 Å and 71 Å for the carboxyl- and amine-functionalized 
EviTags, respectively. Both of these donor-acceptor distances are shorter than half of the 
hydrodynamic diameter of the QDs, as measured with DLS, suggesting that in both cases 
the fluorescent proteins may be embedded in the coating layer rather than outside of the 
PEG corona. The flexibility of the hydrated PEG chains, particularly when not close-
packed into a dense brush-like conformation, could permit this physical arrangement. 
Furthermore, the difference in the donor-acceptor distance for carboxyl-functionalized or 
amine-functionalized EviTags could arise if the amino acid linker region between the 
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His-tag and the FP barrel structure is fully extended when the protein is bound to the 
amine-functionalized EviTag due to the differences in their PEG conformations. 
To ensure that the results of the EviTag FRET assays are not dependent on these 
particular batches of QDs, self-assembly experiments were repeated many times with 
different coating batches and QD emission wavelengths (paired with alternative GFP-like 
FPs to ensure appropriate spectral overlap where necessary) utilizing QDs purchased over 
several years, making it likely that multiple batches of Avanti’s lipid-PEG were involved 
for each coating type as well. Our general observation of strong quenching of the 
carboxyl-functionalized EviTags, moderate quenching of the amine-functionalized 
EviTags, and no quenching of the non-functionalized EviTags was consistent for all 
experiments conducted (data not shown). Our previous results indicated that carboxyl-
functionalized EviTags with three different coating batches all showed considerable 
quenching when bound to FPs via polyhistidine-mediated coordination (15). Thus, we 
believe that these results clearly demonstrate the merit of using polyhistidine 
coordination for the bioconjugation of biomolecules to QDs coated with carboxyl-
functionalized lipid-PEG molecules. 
The schematic in Figure 5.20 diagrams the specific QD-FP interactions that seem to be 
suggested by the data as well as the chemical structures of the various coatings, giving an 





Figure 5.20: Schematic of various QD coatings and His-tag interactions. 
Various coating moieties and their interaction with the polyhisitidine sequence are 
depicted. Where the His-tag can access the QD surface, coordination of the Zn2+ ions in 
the ZnS capping layer facilitate self-assembly. In the case of the carboxylated polymer, a 





In this study, we compared QDs with eight different coatings using three different 
coating schemes and determined their capacity for polyhistidine coordination as a means 
to conjugate biomolecules to nanoparticles by self-assembly. This is highly desirable for 
the assembly of nanoparticle based imaging probes and delivery systems because of its 
technical simplicity. DHLA-coated QDs exhibited effective His-tag-mediated binding 
and short donor-acceptor distances, but are not universally applicable because of their 
low quantum yield, the environmental sensitivity of photoluminescence, and pH-
dependent colloidal instability. Using QDs coated with PEGylated DHLA improved the 
stability and environmental sensitivity, making them advantageous for certain 
applications including intracellular imaging, but the PEGylated coating also precluded 
His-tagged proteins from penetrating to the QD surface, making them unsuitable for His-
tag-mediated conjugation strategies. The ZnS surface of the carboxyl and amino-PEG 
Qdots was similarly inaccessible for His-tag binding, but chelation of supplemented Ni2+ 
to the high density of carboxyl groups on the carboxyl Qdot polymer coating did allow 
for Ni2+-mediated association of the protein with the Qdot, similar to the way in which a 
His-tagged protein binds to a Ni2+-containing metal affinity chromatography column. 
While the added distance between the donor and acceptor resulting from this binding 
scheme may make the strategy suboptimal for FRET-based assays, it may be useful for 
labeling Qdots with proteins for applications where the protein should be completely 
exposed at the QD surface to maintain functionality. Finally, the lipid-PEG coated 
EviTags demonstrated a range of His-tag binding permissiveness, depending on the 
specific functional group at the PEG terminus. Lipid-PEGs terminated with a methyl 
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group generated a thick, impenetrable coating, while coatings with terminal carboxyl-
groups were much thinner and susceptible to His-tag binding. Amine-functionalized 
EviTags performed in between the two.  
As the variety of protocols used to confer water-solubility to QDs diversifies, 
including to small molecule coatings that preserve the high QD QY (50) and QDs 
solubilized directly with biomolecules (51), the potential for discovering other QD 
varieties that are effective FRET donors and accessible for His-tag-mediated self-
assembly increases. Expanding on these techniques to include PEG passivation would 
make them more broadly applicable both in in vitro assays and intracellular imaging. 
The combination of reasonably bright, stable QDs amenable to His-tag mediated 
self-assembly with a PEG coating that could reduce non-specific interactions makes a 
very attractive nanoscaffold for bioconjugation. The fact that differences from minor 
modifications to the coating cannot be fully reconciled suggest far more remains to be 
learned about this particular nanoparticle-biological interface and will help improve the 
design of the next generation of materials.  
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CHAPTER 6  
ASSESSING QUANTUM DOT-FLUORESCENT PROTEIN PAIRS AS 
FLUORESCENCE RESONANCE ENERGY TRANSFER PROBES* 
INTRODUCTION 
Chapter 5 discussed the effect of various quantum dot (QD) coatings and the 
resultant nanoparticle properties on the self-assembly of QDs and His-tagged fluorescent 
proteins (FPs). Here the changes in fluorescence resonance energy transfer (FRET) pair 
properties that result from changes to the QD spectral properties or to the FP acceptor are 
investigated. 
The use of FPs as FRET acceptors has several benefits. Standard molecular 
biology techniques can easily be used to modify the FPs to include the polyhistidine tag, 
a variety of linkers between the protein bulk and the tag, and amino acid sequences that 
could contribute to the functionality of the QD-FRET probe, such as a cleavage sequence 
for a protease to produce a FRET-based probe to measure enzyme activity. Once a 
plasmid for the recombinant protein is designed, FPs can be expressed in E.coli in large 
quantities, and the presence of the polyhistidine on His-tagged proteins facilitates protein 
purification using immobilized metal affinity chromatography (IMAC). The large variety 
of GFP-like fluorescent proteins now available with emission wavelengths spanning the 
entire visible range also provides an array of possible fluorescent protein acceptors for 
QDs with different colors (91, 112). 
The schematic in Figure 6.1 demonstrates how the interaction between a His-
                                                 
* Modified from Dennis AM and G Bao. Quantum dot-fluorescent protein pairs as novel 
fluorescence resonance energy transfer probes. Nano Letters 2008. 8(5):1439-1435. 
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tagged fluorescent protein and a T2-MP carboxyl-functionalized EviTag results in FRET. 
The fluorescent protein self-assembles to the EviTag via polyhisitidine coordination as 
discussed in Chapter 5. When the QD is excited with UV irradiation, it emits at its 
characteristic wavelength. With the FP bound, some of the energy from the QD is 
transferred to the FP and emission is seen from both the QD and the FP in ratios that vary 
depending on the number of FPs attached to the QD, their spectral overlap, and the 
distance between the two. The differences found by varying the QD-FP combinations are 
explored in this chapter. 
 
Figure 6.1: Schematic diagram of the QD-FP FRET interaction.  
A polyhistidine sequence inserted at the N-terminus of the mCherry showen here 
coordinates to the ZnS capping layer of the T2-MP carboxyl-functionalized EviTag, 
bringing the two into close proximity. Under excitation of the QD, energy is non-
radiatively transferred to the fluorescent protein and sensitized emission is observed. 
EviTag image courtesy of Evident Technologies. mCherry produced with PDB Protein 




Quantum Dot and Fluorescent Protein Properties 
The absorbance or excitation and emission spectra of the three QDs and three 
fluorescent proteins used in this study are displayed in Figure 6.2. Summaries of the other 
properties of the donor and acceptor component parts are listed in Table 6.1. 
The absorption and emission spectra of the three different wavelength emitters of 
QDs are very similar, with just a slight red-shifting from one to the next. As expected, the 
wavelength of the emission increases with the size of the QD core-shell structure (32). 
This subtle difference in the semiconductor metal crystal mass is masked by the lipid-
PEG coating, as the hydrodynamic diameters of the three different QDs are reported to be 
about the same (dynamic light scattering measurement, personal communication with 
Kayla Leach from Evident Technologies and product data sheet). 
Table 6.1: Donor and acceptor properties. 


















mOrange 548 562 71,000 0.69 6.4 27 
tdTomato 554 581 138,000 0.69 70 54 
mCherry 587 610 72,000 0.22 68 27 
FRET donor: T2-MP Carboxyl EviTagsb 


















520 ± 10 0.28 7.5 
~25 QD540 540 ± 10 0.35 7.7 
QD560 560 ± 10 0.31 8.0 
a Fluorescent Protein specifications previously published (Shaner, Campbell et al. 2004). 







Figure 6.2: Spectral characteristics of the FRET donors and acceptors.  
Top: Absorbance (dashed lines) and emission spectra (solid lines, with emission peaks 
from left to right) of 520 nm, 540 nm, and 560 nm T2-MP carboxyl-functionalized 
EviTags. Bottom: Excitation (dashed lines) and emission spectra (solid lines, with 




The three fluorescent proteins used in this study have many similarities because 
they are all derived from a common ancestry, but the modifications that were made to 
create the diversity of macromolecules found in the so-called “Fruit Basket” of proteins 
do result in several significant differences. Because of the tandem dimer structure of 
tdTomato, its molecular weight is twice that of monomeric mOrange or mCherry, and its 
molar extinction coefficient is correspondingly doubled as well. Although mOrange and 
tdTomato have the same high quantum yields (QYs), tdTomato is twice as bright as 
mOrange because of this difference in the molar extinction coefficient. Similarly, 
although mCherry and mOrange have the same molar extinction coefficient, mOrange is 
much brighter than mCherry because its QY is three times higher. In addition to these 
differences in FP brightness, mOrange is also much more sensitive to photobleaching and 
changes in pH than the other two FPs (91). 
Overlap Integrals and Förster Distances 
The overlap integral and Förster distances were calculated for each of the nine 
possible FRET pairs using Equations (3) and (4) (page 45). The spectral overlaps of each 
of the possible quantum dot-fluorescent protein pairs are shown graphically in Figure 6.3, 
Figure 6.4, and Figure 6.5, and the calculated values for the overlap integrals and Förster 
distances are presented in Table 6.2. The overlap between mCherry and the QDs 
improved with the increasing emission wavelength of the EviTags. The overlap increased 
for tdTomato and mOrange as they moved from 520 to 540 nm emission wavelength, but 
then decreased with the 560 nm emitting QDs as the QD emitted at a lower energy than 
the FP was absorbing. At this point significant overlap of the QD and FP emission peaks 
also made the deconvolution of the FRET spectra less reliable, so three of the nine 
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possible pairs (QD540-mOrange, QD560-mOrange, and QD560-tdTomato) were not 
included in the FRET study. The Förster distances ranged from 4-6 nm, with the largest 
distances logically correlating with the most complete spectral overlaps, as observed 
visually and through the calculated overlap integral. 
 
 
Table 6.2: Overlap integral and Förster distance for all 




J (10-15 M-1 cm3) 
Förster Distance 
R0 (Å) 
QD520-mOrange 3.74408 47.81 
QD540-mOrange 4.67399 50.52 
QD560-mOrange 1.87209 41.89 
QD520-tdTomato 8.52283 54.84 
QD540-tdTomato 11.2586 58.49 
QD560-tdTomato 8.1611 53.54 
QD520-mCherry 3.33902 46.91 
QD540-mCherry 5.59474 52.06 






Figure 6.3: Spectral overlap of quantum dot donors and mOrange.  






Figure 6.4: Spectral overlap of quantum dot donors and tdTomato.  





Figure 6.5: Spectral overlap of quantum dot donors and mCherry.  





Assay Protocol. Assays examining the FRET efficiency of the various pairs were 
carried out in black, flat-bottomed, nobinding 384-well plates. Alternating serial dilutions 
of fluorescent proteins were made to produce a range of average QD:FP ratios ranging 
from 16 FPs per QD to fewer than 0.2 FPs per QD. T2-MP carboxyl-functionalized 
EviTags were then added to the wells at a final concentration of 50 nM. All of the assays 
were prepared in PBS, pH 7.4, with 1% bovine serum albumin (BSA) added to minimize 
any nonspecific binding. After allowing 15 minutes for self-assembly, the emission 
spectra were measured in a Tecan Safire multiplate reader with an excitation wavelength 
of 400 nm, excitation bandwidth of 12 nm, emission bandwidth of 5 nm, and a step size 
of 3 nm. All of the assays were performed in triplicate, as were FP-only controls.  
Direct Excitation of FPs. Some direct excitation of the FRET acceptor is 
inevitable in FRET assays, although in this case the direct excitation was minimal due to 
the brightness of the QDs, which allows for low concentrations of the donor and thereby 
relatively low acceptor concentrations, and the minimal excitation of the FPs at 400 nm. 
By looking at the spectra in Figure 6.6, one can see that the majority of the FP emission 
in the FRET assays was indeed sensitized emission. The small peak at 500 nm seen in all 
of the samples was not due to the direct excitation of any of the FPs, but rather was 
consistent from well to well and was due to the autofluorescence of the BSA in the 
reaction buffer. Although the direct excitation of the FPs was low, the FP-only 
background control spectra were subtracted from the FRET spectra prior to peak 
deconvolution to improve the accuracy of the peak integrations.  
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Energy Transfer. As seen in Figure 6.7 through Figure 6.12, all three of the His-
tagged fluorescent proteins exhibited an ability to substantially quench the QD emission 
due to FRET, as demonstrated by the across-the-board decrease in the QD emission peak, 
the correlation between the spectral overlap of the donor-acceptor pair and the change in 
the spectra, and the quenching efficiency (Table 6.3). Sensitized emission was observed 
from each of the protein acceptors, although tdTomato and mOrange emitted more 
strongly than mCherry.  
The assays were each repeated using fluorescent proteins lacking the His-tag as 
negative controls to ensure that the QD-FP binding was indeed mediated by the 
polyhistidine, and a second control utilized a short His10 peptide without a fluorophore to 
demonstrate that the binding of the polyhistidine to the core-shell surface was not causing 
contact-quenching of the QD or otherwise affecting the QD emission. 
 




distance R (Å) 
FRET efficiency 
(E) at 1:1 QD:FPa 
Maximum measured 
FRET efficiency (E) 
QD520-mOrange 57.4 ± 6.6 0.261 0.761 
QD520-tdTomato 53.8 ± 3.4 0.428 0.867 
QD540-tdTomato 52.7 ± 3.9 0.504 0.902 
QD520-mCherry 52.0 ± 4.3 0.302 0.713 
QD540-mCherry 56.2 ± 4.5 0.343 0.798 






Figure 6.6: Direct excitation of the fluorescent proteins in the FRET assay.  
A) QD520 + His6-mOrange; B) QD520 + His6-tdTomato; C) QD540 + His6-tdTomato; 
D) QD520 + His6-mCherry; E) QD540 + His6-mCherry; and F) QD560 + His6-mCherry. 
Insets: The background emission from the His6-FPs scaled for clarity. The QD 






Figure 6.7: FRET between 520 nm EviTags and mOrange. 
Top: Emission spectra of 520 nm T2-MP carboxyl-functionalized EviTags incubated with 
His6-mOrange, showing a dose-dependent decrease in QD emission and concomitant 
increase in the sensitized emission of mOrange. 
Bottom: Plot of the relative QD emission versus the number of acceptor molecules per 






Figure 6.8: FRET between 520 nm EviTags and tdTomato. 
Top: Emission spectra of 520 nm T2-MP carboxyl-functionalized EviTags incubated with 
His6-tdTomato, showing a dose-dependent decrease in QD emission and concomitant 
increase in the sensitized emission of tdTomato.  
Bottom: Plot of the relative QD emission versus the number of acceptor molecules per 






Figure 6.9: FRET between 520 nm EviTags and mCherry. 
Top: Emission spectra of 520 nm T2-MP carboxyl-functionalized EviTags incubated with 
His6-tdTomato, showing a dose-dependent decrease in QD emission and concomitant 
increase in the sensitized emission of tdTomato.  
Bottom: Plot of the relative QD emission versus the number of acceptor molecules per 





Figure 6.10: FRET between 540 nm EviTags and tdTomato. 
Top: Emission spectra of 520 nm T2-MP carboxyl-functionalized EviTags incubated with 
His6-tdTomato, showing a dose-dependent decrease in QD emission and concomitant 
increase in the sensitized emission of tdTomato.  
Bottom: Plot of the relative QD emission versus the number of acceptor molecules per 







Figure 6.11: FRET between 540nm EviTag and mCherry. 
Top: Emission spectra of 520 nm T2-MP carboxyl-functionalized EviTags incubated with 
His6-mCherry, showing a dose-dependent decrease in QD emission and concomitant 
increase in the sensitized emission of mCherry. 
Bottom: Plot of the relative QD emission versus the number of acceptor molecules per 






Figure 6.12: FRET between 560 nm EviTags and mCherry. 
Top: Emission spectra of 520 nm T2-MP carboxyl-functionalized EviTags incubated with 
His6-tdTomato, showing a dose-dependent decrease in QD emission and concomitant 
increase in the sensitized emission of tdTomato.  
Bottom: Plot of the relative QD emission versus the number of acceptor molecules per 
QD. Points represent mean ± standard deviation of n = 3. 
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FRET Analysis. Although the direct excitation of the FPs was minimal, the 
background emission was subtracted from each of the FRET spectra at the same FP 
concentration at the beginning of the analysis. Each background–subtracted spectrum was 
then deconvolved as described in the Methods (page 47), and the areas under the QD 
peaks with FRET were normalized to the area under the QD spectrum in the absence of 
FP. The resulting normalized QD emission intensities were plotted versus the acceptor 
concentrations in Figure 6.7 to Figure 6.12. The non-His-tagged FP results were fitted to 
the Stern-Vollmer equation (Equation (6), page 48), which describes collisional 
quenching (4). To estimate the strength of binding between the EviTags and the His-
tagged proteins under steady-state conditions, the His6-FP data were fitted to the 
modified Hill equation (Equation (8), page 49) derived in the Methods (page 48): 




















where FDA is the fluorescence of the donor in the presence of the acceptor, FD is the 
fluorescence of the donor in the absence of the acceptor, Emax is the maximum FRET 
efficiency, c is the concentration of the acceptor, h is the Hill coefficient, and KD is a 
nominal dissociation constant defined as the acceptor concentration at which there is 50% 
quenching of the QDs (106). Note that the nominal KD is not the concentration at which 
there is 50% binding, but rather the concentration at which there is 50% quenching of the 
QD. The two are distinct because the fluorescent quenching is not linearly related to the 
number of acceptors bound (4, 10). All of the curvefit coefficients, including the nominal 
KDs for each FRET pair, are listed in Table 6.4. 
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The donor-acceptor distance was calculated for each pair at each concentration 
using Equation (11) (page 50) and the average and standard deviation is presented in 
Table 6.3. All of the donor-acceptor pairs displayed a separation distance of 5-6 nm. 
While compared with the relatively small differences in the QD sizes the standard 
deviations on these values are too large to allow for correlations to be drawn between the 
QD core-shell radius and the distance between the donor and acceptor, all of the values 
are consistent with the fluorescent protein binding to the QD core-shell surface.  
Ratiometric analysis. To highlight differences in the carious FP acceptors, the 
FRET data were also analyzed using a ratiometric method, where the emission of the 
acceptor was divided by the emission from the donor and plotted as a function of the 
number of proteins per QD (Figure 6.13, top). While all three of the FPS were shown to 
be effective quenchers of the QD emission, this ratiometric analysis demonstrates the 
contrast between the emissions of the three proteins. For example, the three FRET pairs 
containing mCherry showed only a small increase in FA/FD due to the low quantum yield 
of the FP, while the FRET pairs containing tdTomato demonstrated a dramatic increase 
because of the exceptional brightness of tdTomato. mOrange fell between the two in the 
Table 6.4: Summary of curve-fit coefficients. 
 
Coefficients from fitting the His6-FP/QD data 





Pair Emax KD (nM) h KSV 
QD520-mOrange 0.827 ± 0.037 92.7 ± 9.6 1.256 ± 0.103 0.0129 ± 0.0012 
QD520-tdTomato 0.960 ± 0.040 61.2 ± 6.6 1.085 ± 0.090 0.0097 ± 0.0022 
QD540-tdTomato 0.920 ± 0.011 43.2 ± 1.3 1.301 ± 0.044 0.0392 ± 0.0068 
QD520-mCherry 0.755 ± 0.028 72.0 ± 6.7 1.115 ± 0.077 0.0174 ± 0.0021 
QD540-mCherry 0.852 ± 0.014 69.7 ± 3.0 1.101 ± 0.040 0.0104 ± 0.0015 




increase of FA/FD as it possesses a quantum yield as high as that of tdTomato, but like 
mCherry, it has only half the molar extinction coefficient as that of tdTomato due to its 
monomeric form. The distinction between different FPs based on their emission 
properties was further demonstrated in Figure 6.13 (bottom) by plotting the log of FA/FD 
as a function of the FRET efficiency. When the effect of the absorption characteristics of 
the FPs is eliminated, the six QD-FP pairs split into two groups: those containing the 
more efficient emitters mOrange or tdTomato and those containing mCherry. Not that 
tdTomato and mOrange converged almost completely because both have quantum yields 






Figure 6.13: Ratiometric analysis of FRET assays. 
Top: The acceptor emission to donor emission ratio as a function of acceptor 
concentration. Data are represented as a mean ± standard deviation of n = 3. 
Bottom: The log of the acceptor emission/donor emission as a function of FRET 




All six of the QD-FP FRET pairs demonstrated a significant level of energy 
transfer with 26-50% QD quenching at a 1:1 FP:QD ratio and up to 90% quenching at 
higher FP:QD ratios. The non-His-tagged and His10 controls produced minimal 
quenching of the EviTags, demonstrating that the effect was neither due to contact 
quenching nor due to the presence of freely dispersed fluorescent protein, but rather the 
presence of both the polyhistidine and the fluorescent protein was necessary for effective 
quenching.  
The binding of the His-tagged proteins to the EviTags had a nominal KD between 
40 and 100 nM, which is in the range of dissociation constants described for antigen-
antibody binding (114). This binding strength indicates that the His-tag conjugation to the 
commercially-available EviTags should be sufficient for use in in vitro assays. FPs 
containing a His10 N-terminal insertion were also tested in the FRET assay with the 
hypothesis that the longer polyhistidine-tag may increase the binding affinity, as is seen 
in IMAC (115). No significant difference between the nominal KDs of the His6-FPs and 
His10-FPs was observed (data not shown), however, which is consistent with what 
reported in the literature (78). 
All three of the fluorescent proteins tested were effective QD quenchers, but their 
capacity for sensitized emission varied significantly. mOrange and, in particular, 
tdTomato each emitted strongly due to FRET, emitting more strongly than the QD donor 
at high acceptor to donor ratios. In contrast, mCherry emitted relatively weakly, although 
the FRET measured FRET efficiencies were higher than those for mOrange because 
mCherry still absorbed the energy very effectively.  
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While the increased molar extinction coefficient of tdTomato did make it a more 
effective quencher than the monomeric mOrange and mCherry, the difference was not 
dramatic enough for one to choose tdTomato over mCherry when probe size is a concern. 
In the ratiometric analysis, however, the differences due to the FP properties was clear. 
Thus, the difference between the FPs can be exploited in probe design: using the 
quencher-like mCherry allows one to neglect the acceptor emission for a more 
straightforward data analysis, whereas tdTomato is preferred when the ratiometric 
method could be used in data analysis to extend the dynamic range of an assay or to 
minimize the effects of well-to-well variation. 
CONCLUSION 
This study characterized six QD-FP FRET pairs and demonstrated that mOrange, 
mCherry, and tdTomato are efficient FRET acceptors when paired with a quantum dot 
donor. The up to 90% quenching of QD photoluminescence seen here indicates that, 
under the right conditions, QD emission could be modulated in a fashion conducive to 
highly sensitive sensor applications. The large variation of fluorescent protein properties 
that can be achieved through genetic engineering guarantees a wide variety of FRET 
pairs can be constructed, each designed to suit various applications. These findings have 
significant implications for the development of versatile and easily accessible QD-based 




CHAPTER 7  
APPLICATION OF THE QUANTUM DOT-FLUORESCENT PROTEIN PAIR AS 
A RATIOMETRIC pH SENSOR* 
INTRODUCTION 
Intracellular pH is an important modulator of cell function. Even very small 
changes in pH can trigger dramatic cellular responses, and a number of mechanisms 
finely regulate the pH of various sub-cellular domains (116). Imaging intracellular pH 
with high spatial resolution could extend our insight into many physiological or 
pathogenic processes taking place within cells. Fluorescent indicators, most commonly 
fluorescein and its many derivatives, can be used to measure intracellular pH, but are 
typically not suited for precise quantification because single wavelength emitters provide 
no internal control for concentration. Thus, it is unclear whether a change in the 
brightness of the indicator is due to a change in local concentration, which is frequently 
exasperated by the leakage of the dyes, or is truly a result of a pH fluctuation (117). In 
contrast, such an internal control is inherent in ratiometric pH indicators, facilitating 
quantification. In addition, traditional fluorophores often exhibit significant 
photbleaching, hindering their usage for monitoring changes in pH over time. Designing 
pH-sensitive imaging agents based on highly photostable components, such as 
semiconductor quantum dots (QDs), could facilitate time-lapse fluorescence microscopy 
studies that could deepen our understanding of elusive intracellular processes. 
                                                 
* Modified from Dennis AM, Rhee WJ, Sotto D, and G Bao. Quantum Dot-Fluorescent 
Protein Hybrid pH Sensor for Intracellular Imaging, in preparation. 
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With these goals in mind, QDs were used to design a pH-sensitive fluorescence 
resonance energy transfer (FRET) probe. A very few examples of QD-based pH sensors 
have been described in the literature. In fact, the only example of imaging intracellular 
pH with QDs simply relies on the inherent pH instability of minimally passivated QDs. 
As the QDs described were brighter at alkaline pHs than at acidic pHs, the authors 
suggested that they could be used as intracellular pH sensors (118), but because just the 
 
Figure 7.1: Schematic of QD-FP FRET-based pH sensor. 
Numerous GFP-like fluorescent proteins are covalently conjugated to the outer polymer 
layer of 525 nm ITK carboxyl Qdots. When the QD is excited with UV illumination, 
some of this energy is transferred to the protein, resulting in sensitized emission of the 
protein. The efficiency of this energy transfer varies with the protein spectral properties, 
which are pH dependent, resulting in an optical FRET-based pH sensor. 
122 
 
emission intensity of the QD is modulated, it would be very difficult to use this as an 
independent indicator. In another example, an organic ligand, [1,3]oxazine, is used as 
either a quencher or an electron donor to the QD based on its protonation state (16). This 
probe design results in the gradual change in QD photoluminescence over a range of pH 
3-11. Both because of a lack of sensitivity in physiological pHs and the absence of a 
control for concentration, this probe is not proposed for intracellular imaging. 
Two FRET-based, ratiometric pH sensors utilizing a QD donor to a pH sensitive 
dye have been described (17, 18). The first uses the a pH sensitive squarine dye as the 
acceptor, whose molar extinction coefficient decreases as the pH increases with a pKa 
~8.5, (17). While this probe exhibits a pH-dependent shift in the conjugate emission 
spectra, the high pKa does not recommend it for intracellular imaging. The second uses a 
fluoroscien derivative as the FRET acceptor (18). Although this conjugate is poorly 
characterized, it is described as having sensing capabilities over a range of ~pH 5.5 to 8.5 
with a region of insensitivity from 7.0-7.5, precisely where sensitivity is needed for 
intracellular imaging. More successful nanoparticle pH sensors for intracellular imaging 
have been based on using dye-loaded polymer spheres (119, 120). 
As was shown in Chapter 5 and Chapter 6, GFP-like fluorescent proteins have 
been paired with QDs to form FRET probes (15, 84). The high efficiency of energy 
transfer indicates that these FRET pairings could be used effectively in various sensing 
applications. In fact, one QD-FP biosensor has already been developed for monitoring 
protease activity (84). Here we utilize the intrinsic pH sensitivity of mOrange in a new 






The optical properties of two different GFP-like fluorescent proteins were 
evaluated, particularly for their pH sensitivity. The absorbance spectra of mOrange and a 
single point mutation thereof, mOrange M163K, were measured as the pH was titrated 
with 1 N HCl. All titrations were performed in 20 mM PBS supplemented with 1% (w/v) 
bovine serum albumin (BSA) to minimize adsorption of the protein or probe to the 
cuvette walls. The absorption spectra of mOrange show a decrease in the primary 
absorption peak at 547 nm and the development of a secondary peak at 400 nm at low 
pHs (Figure 7.2, top). The lack of isosbestic point indicates that this is not a transition 
between two discrete protein states, but rather is more likely a cooperative effect. The 
molar extinction coefficient of mOrange at 547nm changes with pH, as shown in Figure 
7.2 (bottom). The change in molar extinction coefficient with pH is dramatic and 
relatively sharp with a pKa of 6.9. 
The mutant mOrange M163K similarly shows a decrease in absorption at 547 nm 
and a concomitant increase at 400 nm, but this transition is even more complicated than 
that of mOrange, making clear that this is not a simple phase transition between two 
discrete states (Figure 7.3, top). The molar extinction coefficient at 547 nm shows a 
similarly smooth, if more gradual, transition as that of mOrange with a pKa pf 7.9 (Figure 
7.3, bottom). After titrating with HCl, 1 N NaOH was added to all of the test solutions to 
demonstrate that the change in the spectral profile is reversible. Although in many cases 
the pH of the solution was not brought back to the extreme upper end of the pH range 
tested here (pH 10.0), the intermediate pH shown by the “recovered” spectra on the 
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spectral plots demonstrates that the trace mimics other spectra from the more alkaline pH 
ranges, indicating reversibility. 
Although the irregular absorption spectra of the pH-sensitive proteins, particularly 
mOrange M163K, raised concerns about the predictability of the protein emission with 
respect to pH, the relative regularity of the excitation spectra of each of the proteins 
allayed those concerns. In fact, the excitation spectra of the two protein variants are very 
similar and show that there is no excitation of the fluorophore from the higher energy 
wavelengths that were absorbing at acidic pHs (Figure 7.4 and Figure 7.5). The emission 
spectra of the two proteins also vary in intensity with the pH, but this is not due to a 
change in the FP quantum yield (QY), but rather directly correlates to the amount of light 
being absorbed due to the changing molar extinction coefficient. 
Circular dichroism (CD) spectroscopy was used to ensure that the changes in the 
protein optical properties were not a result of significant changes in the characteristic 
barrel structure of the GFP-like fluorescent proteins. As with the optical spectra, the 
protein was diluted in 20 mM PBS, pH 10.0 (although without the BSA supplementation) 
and was titrated with 1 N HCl. The mean residue ellipticity (MRE) of the His6-mOrange 
M163K mutant did not vary significantly with pH (Figure 7.6, bottom). His6-mOrange, 
in contrast, showed a clear pH-dependent decrease in the negative peak at 218 nm (Figure 
7.6, top). The plot of the magnitude of the MRE at 218 nm with respect to pH (Figure 
7.6, top inset) shows a clear similarity to the plots of other pH-dependent characteristics 






Figure 7.2: Absorbance of mOrange with respect to pH. 
The absorbance spectra of mOrange changes in both magnitude and shape with pH (top), 
which is reflected in the change in the molar extinction coefficient at 547 nm with pH 
(bottom). All measurements started in alkaline buffer and were titrated with 1 N HCl. 
“Recovered” spectrum measured after adding a bolus of 1 N NaOH to acidified solution 
to show reversibility of transition (Note: pH not returned to maximum pH 10.0). Points in 






Figure 7.3: Absorbance of mOrange M163K with respect to pH. 
The absorbance spectra of mOrange M163K changes in both magnitude and shape with 
pH (top), which is reflected in the change in the molar extinction coefficient at 547 nm 
with pH (bottom). All measurements started in alkaline buffer and were titrated with 1 N 
HCl. “Recovered” spectrum measured after adding a bolus of 1 N NaOH to acidified 
solution to show reversibility of transition (Note: pH not returned to maximum pH 10.0). 







Figure 7.4: Fluorescence spectra of mOrange with respect to pH. 
Excitation (top) and emission (bottom) spectra of mOrange with titration with 1 N HCl. 
The excitation spectra were measured with a fixed 585 nm emission wavelength, while 
the emission spectra were measured with excitation at 515 nm. “Recovered” spectra 






Figure 7.5: Fluorescence spectra of mOrange M163K with respect to pH. 
Excitation (top) and emission (bottom) spectra of mOrange M163K with titration with 1 
N HCl. The excitation spectra were measured with a fixed 585 nm emission wavelength, 
while the emission spectra were measured with excitation at 515 nm. “Recovered” 








Figure 7.6: pH-dependent CD spectra of mOrange and mOrange M163K. 
The CD spectra of His6-mOrange (top) and His6-mOrange M163K (bottom) were 
measured as the proteins were titrated with 1 N HCl. The magnitude of the mean residue 
ellipticity (MRE) of his6-mOrange at 218 nm is plotted against pH (top, inset). 
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pH Stability of Qdots 
The fluorescence spectra of a number of QDs with a variety of coatings were 
tested at various pHs and in several different buffers. In our experience, a number of the 
QDs showed significant variations in their PL output at different pHs, making them 
unsuitable as the donor for a QD-FP hybrid pH sensor (data not shown). This was true of 
the 525 nm ITK carboxyl Qdots as well; a decrease in QD emission was observed with 
decreasing pH and was accompanied by a slight red-shifting of the emission peak (Figure 
7.7, top). To see if the Qdot would show similar sensitivity in the conjugated prove, a 
QD-FP hybrid was synthesized using the non-fluorescent GFP-like fluorescent protein 
mCherry-NF. While the corona of proteins that surround the Qdot on the conjugated 
probe appear to lessen the PL decrease as well as eliminating the red-shifting of the peak, 
the QD within the conjugate still demonstrates pH sensitivity that would complicate 
analysis of the pH sensor (Figure 7.7, bottom).  
The presence of 1 % (w/v) BSA was demonstrated to greatly reduce the variation 
in QD PL, most likely by passivating the cuvette surface, thereby reducing nonspecific 
adsorption, which can vary with pH. Both the unconjugated 525 nm ITK carboxyl Qdot 
from Invitrogen and the QD conjugated to the non-fluorescent mCherry-NF showed 
minimal PL variation during titration in the buffer containing BSA.  
Table 7.1: Protein and probe pKas. 
 mOrange mOrange M163K 
Molar Extinction Coefficient 6.9 7.9 
Excitation 6.5 7.5 
Emission 6.8 7.3 
Mean Residue Ellipticity (CD) 6.6 N/A 






Figure 7.7: Qdots and mock probe titrated in PBS. 






Figure 7.8: Qdots and mock probe titrated in PBS supplemented with BSA. 
525 nm ITK carboxyl Qdots (top) and Qdots conjugated to mCherry-NF titrated in 20 
mM PBS with 1% (w/v) BSA. 
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Assembly of FRET Probe 
QD-FP hybrid probes were assembled using covalent chemistry. Specifically, 1-
ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) was used to activate carboxyl 
groups on the surface of 525 nm ITK carboxyl Qdots from Invitrogen, which then formed 
amide bonds with primary amines on the protein. Following reaction at 4˚C overnight, 
centrifugal filtration devices with a 100 kDa MW cutoff were used to remove excess 
EDC and unbound protein. 
Absorption spectroscopy of the conjugated probe and unconjugated Qdots were 
used to determine the probe concentration and the average number of proteins bound to 
each probe. The Qdot concentration, which is equivalent to the probe concentration, was 
calculated using the Beer-Lambert Law and a molar extinction coefficient of 360,000 M-1 
 
Figure 7.9: Probe concentration and composition determination. 
The absorption spectra of the conjugated probe and the Qdots are normalized at 405 nm 
before the Qdot spectrum is subtracted from the probe spectrum, resulting in the spectrum 
of the conjugated protein. 
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cm-1 at 405 nm (Invitrogen product data sheet). The spectra were measured at alkaline pH 
to ensure that the FP was not contributing to the absorbance at this wavelength. 
Subtracting the normalized Qdot emission spectrum from the absorbance spectrum of the 
conjugated probe, both normalized to their absorbance at 405 nm, produces the 
absorbance spectra of the conjugated protein (Figure 7.9). Examination of the spectra 
shows that the Qdots do not contribute significantly to the conjugate absorbance at 547 
nm. The maximum molar extinction coefficient for each of the proteins, as defined by the 
sigmoidal curve fits to the data in Figure 7.2 and Figure 7.3, 60,887 M-1 cm-1 and 48,797 
M-1 cm-1 for mOrange and mOrange M163K, were used to calculate the protein content 
for each probe. 
Minor batch-to-batch variation is seen for each conjugation preparation. The two 
probe batches used for the experiments detailed in this chapter resulted in an average of 
18.4 mOrange molecules per QD and 16.5 mOrange M163K molecules per QD, 
respectively. 
pH Sensor Characterization 
The pH sensor was characterized using fluorescence spectroscopy while being 
titrated. Both the mOrange and mOrange M163K probes showed a characteristic double 
peak at strongly alkaline pHs, which correlates with efficient energy transfer from the 
Qdot to the fluorescent protein. As the pH decreased due to titration with 1 N HCl, the 
protein peak at 560 nm decreased and the QD emission at 520 nm correspondingly 
increased (Figure 7.10 and Figure 7.11, top). The changes in the spectral profile arise as 
the acidic pHs reduce the absorbance capacity of the fluorescent protein. As the protein 
absorbs less of the energy from the Qdot, its own sensitized emission decreases and the 
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emission from the Qdot increases as it is quenched less. The titration increased the 
volume of the sample by < 3%, which did not seem to affect the measurement 
significantly, based on the clear isosbestic point at 545 nm. 
Following the titration, a bolus of 1 N NaOH was added to raise the pH to 
demonstrate the reversibility of the pH sensor. As anticipated, the protein signal was 
restored and the QD emission returned to the lower values originally seen at high pHs 
(“recovered” spectrum in Figure 7.10 and Figure 7.11, top). Both the QD and protein 
signals were slightly lower than observed in the original spectra, which is likely 
attributable to the dilution factor from the titrations. 
The titrations were repeated in triplicate and the ratio of the acceptor emission to 
the donor emission (FD/FA, i.e. F560 nm/F520 nm) was plotted versus pH. The spectral and 
combined plots of both of the pH sensors were very similar. The mOrange M163K-based 
sensor showed smaller standard deviations in the averaged study, indicating a significant 
repeatability and clearly distinguishing one pH value from another. While the standard 
deviations for the mOrange-based sensor were still small, there was some overlap among 
the pH values tested. Both probes showed considerable change in FD/FA with pH. The 
mOrange probe showed a more than 20-fold increase overall with an 8-fold increase in 
the FD/FA between 6.1 and 8.0. The mOrange M163K probe exhibited a 16-fold increase 
overall and an 8-fold increase in the FD/FA from pH 6.3 to 8.3. Although the pH ranges of 
interest overlap, the pKa of the mOrange probe was 7.0 while that of the mOrange 
M163K probe was 7.4.  
The fluorescence emission of the Qdot mixed with, but not conjugated to 
mOrange was tested at the same concentrations and same conditions as the probe at pH 
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10. Absolutely no sensitized emission was discernable, demonstrating that the mOrange 







Figure 7.10: Titration of mOrange FRET probe. 
Top: Emission spectra of mOrange FRET probe with respect to pH. Recovered spectrum 
demonstrates reversibility of pH-sensitivity. 
Bottom: Acceptor emission to donor emission ratio versus pH. Points represent mean ± 






Figure 7.11: Titration of mOrange M163K FRET probe. 
Top: Emission spectra of mOrange FRET probe with respect to pH. Recovered spectrum 
demonstrates reversibility of pH-sensitivity. 
Bottom: Acceptor emission to donor emission ratio versus pH. Points represent mean ± 




mOrange, a member of the “Fruit Basket” family of GFP-like fluorescent proteins 
developed in Roger Tsien’s laboratory at the University of California, San Diego (91), is 
an excellent FRET acceptor because of its high molar extinction coefficient and QY, but 
has not been generally applied because it is rather photolabile compared to other GFP-
like fluorescent proteins and exhibits a pH sensitivity that is undesirable in many 
applications (112). The FRET probe design described here, however, exploits the pH 
sensitivity of mOrange to produce a pH sensor that could be used in either solution 
studies or intracellularly while mitigating the effects of the rapid photobleaching of 
mOrange by using the QD as the FRET donor. By exciting the probe at 400 nm rather 
than at the peak absorbance wavelength of mOrange, less light is being absorbed by the 
protein fluorophore, limiting the protein exposure to destructive photonic energy. 
A protein variant, mOrange M163K, was described in the literature as being more 
photostable than mOrange and possessing an increased pKa (92). We included this protein 
in the study as well to broaden the repertoire of pH-sensitive probes to focus on various 
pH points. The absorption spectra of mOrange M163K proved to have a more 
complicated spectral transition in response to pH titration than mOrange did, indicating 
that there may be a more involved structure-function relationship affecting the pH-
sensitivity of this mutant. Although the absorbance spectra of both proteins shows 
significant blue-shifting as the pH decreases—and the emergence of a significant peak at 
400 nm—these peaks are not in fact present in the excitation spectra of the proteins, thus 
they minimally impact the performance of the FRET probes. 
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CD spectra of the two titrated proteins were examined to ensure that the change in 
the protein optical properties was not a result of protein degradation. mOrange M163K 
showed negligible change in MRE as the pH was titrated down, but mOrange showed a 
subtle, but pH-dependent decrease in the size of its peaks. Although it is clear that the 
general structure of the protein remains intact, it is possible that the mOrange secondary 
structure relaxes somewhat in response to the change in pH. The ancestral DsRed, like 
mOrange M163K, contains a lysine at amino acid residue 163. Analysis of the crystal 
structure of DsRed indicated that the lysine forms a salt bridge with the phenolate oxygen 
of the chromophore (96). This interaction, absent in mOrange, may add the stability that 
prevents the mOrange M163K CD spectra from shifting in response to changes in pH. 
Both the absorbance and emission spectra of the two mOrange mutants vary with 
pH, although the changes in the brightness of the protein appear to be a result of the 
change in the molar extinction coefficient and not due to a change in the quantum yield of 
the protein. This pH-dependence of the mOrange molar extinction coefficient makes the 
protein particularly useful as a FRET acceptor. As both the amount of donor quenching 
and the extent of the sensitized emission from the acceptor will be affected by the pH-
dependent changes in mOrange’s spectral properties, the change in the ratio of the 
acceptor and donor emissions is more dramatic, which increases the sensitivity of the 
probe. CdSe/ZnS core-shell QDs have been shown to have pH sensitive PL in the 
literature, which could have been a complicating factor in this pH sensor design (121), 
but the polymer coating appears to shield the nanoparticle from the environment, 
eliminating the effect of pH once precautions are taken to guard against adsorption. 
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The pKas of both of the proteins are between 6 and 8, depending on the protein 
and specific definition of the pKa used, which indicates that the spectral properties of the 
proteins will change most dramatically in a pH range that is physiologically interesting. 
The mOrange probe has a stronger FRET signal at cytoplasmic pHs that then decreases in 
acidic environments. This lends the probe to studies such as the tracking of 
nanoparticulates through the endocytic pathway. The mOrange M163K probe, in 
contrast, shows much greater variation in its ratiometric measurement at normal 
physiological pHs, indicating that it may be useful for seeing subtle differences in 
cytoplasmic pH due to cell status, such as cell growth, division, and movement. 
The use of the QD-FP hybrid FRET probe has two distinct advantages over using 
the fluorescent protein alone. The first is that the ratiometric measurement allows one to 
correct for concentration. This property allows for confident comparisons between cells 
and sub-cellular compartments, as it ensures that differences in signal are not due to non-
uniform accumulation of the probe, but are truly indications of changes in the pH. 
Second, by exciting the probe in the UV, far from where the protein is excited, the 
amount of photonic energy absorbed by the chromophore is dramatically reduced, 
extending the functional lifetime of the fluorescent protein. Thus, the QD-FP pH sensor 
could potentially be used for time-lapse imaging studies, whereas mOrange alone shows 
visible signs of photobleaching even as one is focusing the microscope. 
The literature suggests that FRET-based biosensors can be useful in intracellular 
imaging applications if the change in the FRET efficiency in response to the stimulus is 
greater than 0.1 and the change in the donor-acceptor ratio is greater than 30% of the 
original ratio ((Rmin – Rmax)/Rmin ≥ 30%) (101). Based on those criteria, either of the 
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probes described here have potential as intracellular imaging probes. These probes are 
bright, show relatively high FRET efficiencies, and are very sensitive to their analyte, H+. 
Future iterations of the probe could perform even better, however, if the donor-acceptor 
distance could be reduced without diminishing the QY of the QD. While the thick 
polymer coating on the Qdots may be necessary to prevent QD PL fluctuations in 
response to pH, it is also possible that QDs with thinner coatings could be buffered by the 
corona of proteins on the conjugated probe to maintain their stability. This will be an area 
of continued probe development. 
CONCLUSION 
This example of a functional QD-FP biosensor demonstrates how the innate sensitivity of 
an FP to its environment can be harnessed to modulate QD emission. As the molar 
extinction coefficient of mOrange decreases with pH, the QD emission increases until it 
is completely unquenched at acidic pHs. The sensitivity of the ratiometric measurement 
over a physiologically relevant pH suggests that this probe may be effective in 




CHAPTER 8  
CONCLUSIONS AND FUTURE DIRECTIONS 
Burgeoning progress in the field of nanobiotechnology holds great promise for 
improving biomedical research and disease diagnostics as biosensors become more 
sensitive. By investigating basic principles of inorganic-biomolecule hybrid device 
design and applying the knowledge gained to the implementation of a pH sensor, this 
thesis contributes to the advancement of the field. 
First, a systematic study was undertaken to evaluate various QDs, differentiated 
by their organic coating, for their capacity to self-assemble with protein via polyhistidine 
coordination. Our results showed that QDs with thin or porous coatings were amenable to 
His-tag binding, indicating the accessibility of the surface of the semiconductor 
nanocrystal. The demonstration of successful binding to QDs with several coatings, 
including commercially available varieties, expanded the range of known options 
available for QD-biomolecule hybrids assembled via His-tag-mediated self-assembly. 
Furthermore, the examination of what QD parameters determined whether or not self-
assembly would be successful enables the prediction of what other coating types are most 
likely to behave similarly. 
Based on the results of the self-assembly analysis, lipid-PEG coated QDs were 
chosen for a study to identify viable QD-FP pairings for FRET biosensors. QDs with 
three emission wavelengths and three fluorescent proteins, mOrange, mCherry, and 
tdTomato, were evaluated for their FRET efficiency. Several effective FRET pairs were 
identified, including 520 nm QDs and mOrange, 540 nm QDs and tdTomato, and 560 nm 
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QDs and mCherry. The differences in the FP properties enabled a closer look at 
analytical methods, demonstrating that some FRET pairs are best scrutinized by their 
FRET efficiency and donor quenching, whereas ratiometric methods are highly beneficial 
for those FPs the exhibit high levels of sensitized emission. 
Finally, we demonstrated the application of a QD-FP hybrid probe in the form of 
a FRET-based, ratiometric pH sensor. Two monomeric fluorescent proteins, mOrange 
and mOrange M163K, were evaluated for their pH-dependent optical properties and their 
effectiveness as FRET acceptors to a QD donor. With an up to 20-fold change in the 
acceptor emission to donor emission ratio over a pH range that is physiologically 
interesting, these probes have promise as intracellular imaging agents. Potential 
applications include endosomal tracking or the elucidation of delivery pathways used by 
various cell-penetrating peptides for model nanoparticle-protein drug delivery devices. 
The specific experiments described in this thesis lead to a number of conclusions 
regarding the affect that QD organic coatings have on polyhistidine-mediated self-
assembly, the various QD-FP pairings available for device design, and the design aspects 
that affect the performance of the pH sensor. Moreover, these results invite a variety of 
future studies that improve on device design and expand the applications of QD-FP 
FRET biosensors. Several of these potential studies are described below. 
IMPROVING THE QD-FP FRET PROBE PERFORMANCE 
QD Donors 
While the QD is undoubtedly a successful FRET donor, as demonstrated by the 
studies in this thesis as well as other studies in the field, several improvements in the QDs 
available for use in the FRET probes could have a dramatic impact on the FRET 
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efficiency of the probes. As discussed in Chapter 3, the FRET efficiency of a system is 
primarily influenced by three variables: the spectral overlap of the donor and acceptor, 
the quantum yield of the donor, and, most dramatically, the donor-acceptor distance. The 
tunability of QD emissions already guarantees that high levels of spectral overlap 
between the donor and acceptor can be assured by choosing the right donor for the 
desired acceptor. Improvements could be made, however, in the QD quantum yield and 
donor-acceptor distance. While water-soluble QDs with high QYs have been available, 
even commercially, for several years now, the QDs that have the highest QYs are also 
typically larger, owing to ZnS capping layers to improve the nanocrystal QY (25, 26) and 
typically thicker organic coating layers that maintain the higher QYs by not disrupting 
the hydrophobic surfactant layer left on the particle surface following the inorganic 
synthesis. This larger QD size contributes to expanded donor-acceptor distances, thereby 
mitigating the effects of the improvements in FRET efficiency that could have been seen 
with the higher QY. Several improvements in QD core-shell synthesis protocols and in 
coating procedures indicate that convenient access to small, high QY QDs with thin 
organic coatings that are appropriate FRET donors is on the horizon. Approaches include 
implementing alternative nanocrystal compositions, such as CdTeSe alloys or lattice 
mismatched core-shell structures that produce bright nanocrystals with small inorganic 
diameters (33, 34). Additionally, gentler ligand exchange coating protocols claim to 
maintain QD QYs while conferring water-solubility with minimal coatings (50, 51), and 
multi-dentate coatings have the potential for increased colloidal stability despite the small 
size (52). When these incremental changes are taken together, the improvements to FRET 
efficiency and, therefore, probe sensitivity could be dramatic.  
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Fluorescent Protein Acceptors 
Developments in FP engineering have resulted in a wide range of FPs to choose 
from when designing QD-FP hybrid probes. The range of colors and spectral properties is 
astonishing, but further developments will improve the repertoire even further. Biosensor 
design will improve as FPs with improved photostability, increased brightness, and 
narrower spectral peak profiles emerge. Furthermore, FPs with absorption and emission 
in the near-infrared (NIR; 650-900 nm) would pair nicely with existing and future QDs. 
NIR-based FRET probes would be of key interest for in vivo studies, as tissue is most 
transparent at these wavelengths, with penetration depths extending into centimeters 
(122). 
In addition to using fluorescent proteins as protein acceptors, non-fluorescent 
chromoproteins could be alternative FRET acceptors. The use of such “protein 
quenchers” could allow for the multiplexing of QD-FP FRET-based sensors as the 
emission from the FP would not interfere with the multiplexing advantages of the QDs. 
One such protein, REACh1, is a dark YFP variant that has been used as a FRET acceptor 
for GFP. A single point mutation to EYFP, Y145W, reduced the fluorescence emission 
from the protein by 98%, while the absorbance profile and molar extinction coefficient 
was maintained (123). The absorbance spectra of REACh1 makes it an appropriate FRET 
acceptor for blue-emitting QDs. As another study has identified mutations to the 
tetrameric protein DsRed, the ancestor of the Fruit Basket proteins, that produced a non-
fluorescent chromophore named DsRed-NF (124), it is highly likely that mutations to the 
stably monomeric mFruit proteins could result in a series of monomeric, non-fluorescent 
chromoproteins with a range of absorbance spectra peaks. Such proteins could be used to 
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quench QD emission to create a series of biosensors that could be multiplexed for 
efficient multiparameter sensing. In particular, probes containing protein quenchers as the 
FRET acceptor could be used in fluorescence lifetime imaging (FLIM) to provide an 
alternative to ratiometric sensing that is more amenable to multiplexing (6). Like 
ratiometric methods, FRET-FLIM is inherently quantitative and concentration 
independent (125), but as only the QD emission would be of consequence, many more 
sensors could be spectrally accommodated. 
OTHER APPLICATIONS OF QD-FP BIOSENSORS 
Sensing by Modulating the FP Properties 
Similarly to the mOrange pH sensor, other biosensors could be developed that 
take advantage of natural modulation of FP spectral properties based on environmental 
cues. Examples include the copper-sensitivity of DsRed (126) and the sensitivity of 
various YFP mutants to chloride (127, 128). As was discussed for the pH sensor, using 
the FP in tandem with the QD improves upon just using the FP alone because it controls 
for changes in probe concentration, extends the lifetime of the probe by reducing the 
photobleaching of the protein, and enables fluorescence lifetime measurements, 
expanding on the analytical options. Genetic screens on mutants could be performed to 
select for sensitivity to other small-molecule analytes of interest. 
Genetic engineering of binding pockets into the proteins could further expand the 
range of QD-FP FRET-based biosensors that are modulated by changes in the spectral 
changes of the GFP-like protein. In one instance, for example, the emission of a modified 
EGFP was quenched upon the binding of bacterial endotoxin (or lipopolysaccharide, 
LPS) to a binding region engineered into the barrel structure of the FP (129). Any such 
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existing GFP-like protein-based sensor could be adapted to the QD-FP FRET system by 
conjugating it to a QD. Such adaptations could improve the biosensors in all of the ways 
previously discussed—i.e. controlling for concentration fluctuations, reduced 
photobleaching of the FP, possibility of FRET-FLIM imaging—but eliminates one 
advantage of the protein biosensors: the genetically encoded probes can be expressed by 
cells following transfection; there is no need for more strenuous probe delivery protocols. 
Sensing by Modulating Donor-Acceptor Distance 
As demonstrated in Figure 3.7, a number of FRET-based biosensor designs center 
around changing the donor-acceptor distance, rather than modulating the optical 
properties of the acceptor. Theoretically, any of these sensing designs could be applied to 
QD-FP biosensors as well. In fact, one recent publication demonstrates the utility of a 
QD-FP FRET-based probe for protease activity (Figure 8.1) (84). Any of the FP-to-FP 
FRET-based biosensors whose research value could be improved by enhancing the signal 
output, reducing crosstalk, and reducing photobleaching could be adapted to this QD-FP 
 
Figure 8.1: QD-FP FRET-based assay for proteolytic activity. 
mCherry bound to the CdSe/ZnS QD via a polyhistidine tag quenches the QD until the 
linker between the FP and the his-tag is enzymatically cleaved, releasing the protein from 
the QD surface. In the absence of the bound FP, the QD emission is restored. Reprinted 






















Caspase 3 substrate linker 1:
Caspase 3 extended substrate linker 2:
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sensor format. QD-FP sensors are not, however, genetically encodable as the FP-FP 
biosensors are, so probe delivery will have to be addressed for intracellular imaging 
applications. 
INTRACELLULAR IMAGING OF QD-FP FRET PROBES 
The literature suggests that FRET-based biosensors can be useful in intracellular 
imaging applications if the change in the FRET efficiency in response to the stimulus is 
greater than 0.1 and the change in the donor-acceptor ratio is greater than 30% of the 
original ratio ((Rmin – Rmax)/Rmin ≥ 30%) (101). The pH sensor described in Chapter 7 
certainly clears this hurdle, making it a prime candidate for live-cell imaging.  
The first concern for any intracellular imaging application with QD-based probes 
is the delivery of the probe into the cell. As some success has been had using cell 
penetrating peptides to deliver a QD and its protein cargo via endocytosis (110), we have 
engineered an mOrange variant that includes nine arginines at the C-terminus. 
Preliminary experiments have been conducted to evaluate this QD-mOrange-Arg9 probe 
for fluorescence microscopy. While our initial impressions, both of delivery and of probe 
function, are promising, much work remains to convincingly demonstrate the probe 
function intracellularly. 
In conclusion, the projects contained in this thesis describe a new biosensing 
platform that combines the unique optical properties of QDs with the intrinsic 
bioresponsive elements of FPs. While issues of probe design and development are 
investigated and a functional biosensor described, examination of this new type of hybrid 
probe has only just begun. Many opportunities exist for future projects, whether that be in 
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improving on the current design of the pH sensor, applying the sensor to intracellular 
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